Studies in Rhodium Catalyzed Intramolecular C-H Insertion of Amino Acid Derived α-Diazo-α-(substituted)acetamides and its Application to the Total Synthesis of \u3cem\u3eclasto\u3c/em\u3e-Lactacystin β-Lactone by Flanigan, David L, Jr.
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
5-24-2004
Studies in Rhodium Catalyzed Intramolecular C-H
Insertion of Amino Acid Derived α-Diazo-α-
(substituted)acetamides and its Application to the
Total Synthesis of clasto-Lactacystin β-Lactone
David L. Flanigan Jr.
University of South Florida
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the American Studies Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Flanigan, David L. Jr., "Studies in Rhodium Catalyzed Intramolecular C-H Insertion of Amino Acid Derived α-Diazo-α-
(substituted)acetamides and its Application to the Total Synthesis of clasto-Lactacystin β-Lactone" (2004). Graduate Theses and
Dissertations.
https://scholarcommons.usf.edu/etd/1037
  
 
 
Studies in Rhodium Catalyzed Intramolecular C-H Insertion of Amino Acid Derived α-
Diazo-α-(substituted)acetamides and its Application to the Total Synthesis of clasto-
Lactacystin β-Lactone 
 
 
by 
 
 
 
David L. Flanigan Jr. 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Chemistry 
College of Arts and Sciences 
University of South Florida 
 
 
 
Major Professor:  Kyung Woon Jung, Ph.D. 
Edward Turos, Ph.D. 
Kirpal S. Bisht, Ph.D. 
Julie P. Harmon, Ph.D. 
 
 
Date of Approval: 
May 24, 2003 
 
 
 
Keywords: γ-lactam, natural product, C-H activation, aldol, proteasome inhibitor 
 
© Copyright 2004, David L. Flanigan Jr. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For Liz, Bren and Kristen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Acknowledgments 
 
 First, I need to thank God for providing me with the ability to succeed in this field, without 
Him none of this is possible.  
 Liz, you help me to realize my own potential and never underestimate my ability. Thank you 
for always believing in me and putting up with my “nonsense.” Bren, you constantly bring a 
smile to my face despite hard days of failure and nothing has changed. My family, both 
immediate and extended, have been supportive in countless ways. They have been friends, hosts, 
sources of joy and voices of reason (and not :). They have assisted with financial issues and 
furnished houses. Obviously, they have played an extraordinary part in making my life happier 
and easier and to them I am forever grateful. 
 Dr. Jung, thank you for your encouragement and support during the last four years. Your 
guidance and criticism, though not always understood at the time, has changed me for the better 
both personally and professionally. I appreciate you bringing me into your lab and allowing me to 
study under your guidance. 
 There are so many other people who deserve mention in this part that I’ll most likely run out 
of room. My committee members and faculty/staff friends in the department always support and 
assist me and I appreciate and value each and every one of them. Those friends that I met and 
spent so much time with are, first and foremost, Dr. Jay Parrish and Dr. Advait Nagle. You guys 
are truly special to me. Of course, Dr. Yoon taught me how to draw (really, it is important to us). 
There are also those who I saw every day and shared a laugh or vent session with. They are, in no 
special order, Young, Chiliu, Dr. Mishra, Rob, Woogie, Kisoo, Dr. Yoo, Michelle, Iris, Matt, 
Chong, Vince, Dr. Reddy, Dr. Reddy, Dr. Hwang, Dr. Riley, Christina, Thushara, Hla, 
Santhisree, Cindy and anyone else who slips my mind at the moment. Though the work was hard, 
we had some really good times!
 i
 
 
 
Table of Contents 
 
 
List of Tables   iii 
 
List of Figures   iv 
 
List of Schemes  v 
 
List of Abbreviations  viii 
 
Abstract   xv 
 
Chapter One: Introduction 1 
 1.1 Background 1 
 1.2 Kinetic Inhibition Studies 2 
 1.3 Outlook 4 
 
Chapter Two: Previous Syntheses 6 
 2.1 Corey’s First Total Synthesis of Lactacystin 6 
 2.2 Corey’s Extended Methodology 9 
 2.3 Smith’s Total Synthesis of Lactacystin 10 
 2.4 Corey’s Expanded Studies 12 
 2.5 Baldwin’s Total Synthesis of Lactacystin 12 
 2.6 Chida’s Total Synthesis of Lactacystin 14 
 2.7 Corey’s Second Total Synthesis of Lactacystin 16 
 2.8 Kang’s First Total Synthesis of Lactacystin 18 
 2.9 Kang’s Second Total Synthesis of Lactacystin 19 
 2.10 Adam’s Total Synthesis of Lactacystin Analog PS-519 21 
 
Chapter Three: Stereogenic γ-Lactams via Rhodium Catalyzed  
 Intramolecular C-H Insertion 25 
 3.1 C-H Insertion of the Acyclic System 25 
 3.2 C-H Insertion of the Cyclic System 28 
 3.3 C-H Insertion of Amino Acid Derived α-Diazo-α-(phenylsulfonyl) 
  acetamides 31 
 ii
 3.4 C-H Insertion of α-Diazo-α-(substituted)acetamides 35 
 3.5 C-H Insertion of a Conformationally Constrained Cyclic System 42 
 
Chapter Four:  Jung’s Total Synthesis of clasto-Lactacystin β-Lactone 45 
 4.1 Retrosynthetic Analysis of clasto-Lactacystin β-Lactone 45 
 4.2 First Generation Synthesis of the Bicyclic γ-Lactam Intermediate 46 
 4.3 Functionalization of the γ-Lactam Core 48 
 4.4 Second Generation Synthesis of the Bicyclic γ-Lactam Intermediate 50 
 4.5 Stereoselective Functionalization of the Bicyclic γ-Lactam 53 
 4.6 Elucidation of Aldol Stereoselectivity 56 
 4.7 Rationalization for Aldol Coupling Stereoselectivity 58 
 4.8 Endgame for the Total Synthesis of clasto-Lactacystin β-Lactone 59 
 
Chapter Five: Experimental Data 62 
 
References   108 
 
Appendices   113 
 Appendix A: Selected 1H NMR and 13C NMR Spectra 114 
 Appendix B: X-ray Crystallographic Data 157 
 
 iii
 
 
 
List of Tables 
 
 
 
Table 3-1 C-H Insertion of α-Diazo Substrates at the Methylene 
 Position 31 
 
Table 3-2 C-H Insertion of α-Diazo Substrates at Methyl and 
 Methine Positions 33 
 
Table 3-3 C-H Insertion of α-Diazo Substrates at Electron Rich 
 Methylene Positions 34 
 
Table 3-4 C-H Insertion of α-Diazo Substrates with Varied 
 α-Substituents 37 
 
Table 3-5 C-H Insertion of α-Diazo Norvaline Derivatives 41 
 
Table 3-6 C-H Insertion of Conformationally Constrained N,N’-Acetonide 
Substrates with Varied α-Substituents 43 
 
 iv
 
 
 
List of Figures 
 
 
Figure 1-1 Schematic Diagram of  the 20S Proteasome Upon Inhibition 
 by Lactacystin 1 
 
Figure 1-2 Kinetic Inhibition Studies of Lactacystin Analogs 3 
 
Figure 1-3 Kinetic Inhibition Studies of β-Lactone Analogs 4 
 
Figure 2-1 Chelate Model for the Double Diastereoselective Mukaiyama 
 Aldol Coupling 9 
 
Figure 2-2 Stereochemical Rationalization of the Doubly 
 Diastereoselective Aldol Coupling 23 
 
Figure 4-1 Transition States for Quaternary C-5 Formation 58 
 
Figure 4-2 Rationalization of Aldol Coupling Stereoselectivity 59 
 
 v
 
 
 
List of Schemes 
 
 
Scheme 2-1 Corey's Synthesis of the First Key Lactacystin Intermediate 7 
 
Scheme 2-2 Completion of the First Total Synthesis of Lactacystin 8 
 
Scheme 2-3 The Smith-Omura Total Synthesis of Lactacystin 10 
 
Scheme 2-4 Baldwin's Total Synthesis of Lactacystin 13 
 
Scheme 2-5 Chida's Total Synthesis of Lactacystin 15 
 
Scheme 2-6 Corey's Second Enantioselective Total Synthesis of 
 Lactacystin 17 
 
Scheme 2-7 Kang's First Synthesis of a Key Intermediate of Lactacystin 18 
 
Scheme 2-8 Kang's Second Synthesis of a Key Intermediate of Lactacystin 20 
 
Scheme 2-9 Synthesis of the trans-Oxazoline Coupling Partner 21 
 
Scheme 2-10 Synthesis of the α-Alkyl-β-formyl Amide Coupling Partner 22 
 
Scheme 2-11 Endgame of Adams’ Total Synthesis of PS-519 23 
 
Scheme 3-1 Rhodium Catalyzed Intramolecular C-H Insertion of 
 α-Diazo-α-(phenylsulfonyl)acetamides 26 
 
Scheme 3-2 Conformational and Stereochemical Effects on C-H Insertion 27 
 
Scheme 3-3 Synthesis Stereogenic γ-Lactams From α-Amino Acids 28 
 
 
 
 
 vi
Scheme 3-4 Conformational and Stereochemical Effects on C-H Insertion 
 of α-Amino Acid Derivatives 29 
 
Scheme 3-5 Conformational Requirements for Intramolecular C-H 
 Insertion 30 
 
Scheme 3-6 Functionalized Stereogenic γ-Lactams are Versatile Synthetic 
 Intermediates 34 
 
Scheme 3-7 Improved Synthetic Protocol for Analog Synthesis 36 
 
Scheme 3-8 Pathway for C-H Insertion of α-Diazo Substrates Resulting 
 in Aromatic Cycloaddition 38 
 
Scheme 3-9 Conformational Constraint of Cyclic System Inhibits β-Lactam 
 Formation 39 
 
Scheme 3-10 Synthetic Protocol for Norvaline Analog Synthesis 40 
 
Scheme 3-11 Synthesis of N,N’-Acetonide Substrates with Varied 
 α-Substituents 42 
 
Scheme 4-1 Retrosynthetic Analysis of the Total Synthesis of 
 clasto-Lactacystin β-Lactone 46 
 
Scheme 4-2 Amide Coupling of (L)-Serine Methyl Ester 47 
 
Scheme 4-3 Installation of the N,O-Cyclic System 47 
 
Scheme 4-4 Intramolecular C-H Insertion of the (L)-Serine Derived 
 α-Diazo-α-(phenylsulfonyl)acetamide 48 
 
Scheme 4-5 Functionalization of the γ-Lactam 48 
 
Scheme 4-6 Functionalization of the C-5 center 49 
 
Scheme 4-7 Unsuccessful Aldol Coupling 49 
 
Scheme 4-8 Synthesis of the Acetonide Derivative of (L)-Serine 51 
 
Scheme 4-9 Synthesis of the α-Diazo-α-(phenylsulfonyl)acetamide 51 
 
Scheme 4-10 γ-Lactam Formation via Rhodium Catalyzed Intramolecular C-H  
 Insertion  52 
 vii
 
Scheme 4-11 Functionalization of the C-3 Center 53 
 
Scheme 4-12 Selective α-Methylation of the C-3 Center 54 
 
Scheme 4-13 Functionalization of the C-5 Center 54 
 
Scheme 4-14 Stereoselective Formation of the Quaternary C-5 Center 55 
 
Scheme 4-15 Formation of the Quaternary C-5 Center of the 3R 
 Intermediate 55 
 
Scheme 4-16 Oxidation of the C-9 Stereocenters for Structural 
 Elucidation 57 
 
Scheme 4-17 Acylation of the Iminoether Occurs with Enhanced Selectivity 57 
 
Scheme 4-18 Endgame for the Total Synthesis of clasto-Lactacystin 
 β-Lactone 60 
 viii
 
 
 
List of Abbreviations 
 
 
1,2-DCE     1,2-dichloroethane 
 
13C NMR     C-13 nuclear magnetic resonance 
 
1H NMR     proton nuclear magnetic resonance 
 
2,2-DMP     2,2-dimethoxypropane 
 
2,6-lut      2,6-lutidine 
 
Ac      acetyl 
 
Ac2O      acetic anhydride 
 
AcOH      acetic acid 
 
AD-mix     asymmetric dihydroxylation mix 
 
BF3·OEt2     boron trifluoride diethyl etherate 
 
Bn      benzyl 
 
BnBr      benzyl bromide 
 
BOC      t-butoxy carbonyl 
 
BOMCl     benzyloxymethyl chloride 
 
BOPCl      bis(2-oxo-3-oxazolidinyl)phosphinic 
chloride 
 
BrCH2COBr     bromoacetyl bromide 
 
 ix
CBz      benzyloxy carbonyl 
 
CDCl3      chloroform-d 
 
CF3CH2OH     trifluoroethanol 
 
(CH2O)n     paraformaldehyde 
 
CH2(OMe)2     dimethoxymethane 
 
CH2Cl2     methylene chloride 
 
CH2N2      diazomethane 
 
CH3COBr     acetyl bromide 
 
Cl3CCN     trichloroacetonitrile 
 
ClCO2C(CH3)=CH2    isopropenyl chloroformate 
 
ClCOCH2CO2Et    ethyl 4-chloroacetoacetate 
 
cm-1      wavenumbers 
 
(COCl)2     oxalyl chloride 
 
CsF      cesium fluoride 
 
DBU      1,8-diazabicyclo[5.4.0]undec-7-ene 
 
DCC      N,N’-dicyclohexylcarbodiimide 
 
de      diastereomeric excess 
 
DIBAL-H     diisobutylaluminum hydride 
 
DIC      N,N’-diisopropylcarbodiimide 
 
DIPEA     diisopropylethylamine 
 
DMF      N,N-dimethylformamide 
 
DMS      dimethylsulfide 
 
ee      enantiomeric excess 
 x
 
Et      ethyl 
 
Et2NH      diethylamine 
 
EtOAc      ethyl acetate 
 
EtOH      ethanol 
 
H2      hydrogen 
 
H2CO      formaldehyde 
 
H2CrO4     chromic acid 
 
H2SO4      sulfuric acid 
 
HCl      hydrochloric acid 
 
HCO2H     formic acid 
 
HCO2NH4     ammonium formate 
 
HF      hydrofluoric acid 
 
Hg(O2CCF3)2     mercury (II) trifluoroacetate 
 
HONH2·HCl     hydroxylamine HCl salt 
 
HS(CH2)3SH     1,3-propanedithiol 
 
Imid      imidazole 
 
IPA      isopropanol 
 
i-Pr      isopropyl 
 
i-PrCHO     isobutyraldehyde 
 
i-PrMgBr     isopropylmagnesium bromide 
 
Jones Reagent     H2CrO4 solution 
 
K2CO3      potassium carbonate 
 
 xi
KMnO4     potassium permanganate 
 
LAH      lithium aluminum hydride 
 
LDA      lithium diisopropylamide 
 
LHMDS     lithium bis(trimethylsilyl)amide 
 
LiBH4      lithium borohydride 
 
LiBr      lithium bromide 
 
LiOH      lithium hydroxide 
 
LiOOH     lithium peroxide 
 
M      molarity 
 
m-CPBA     3-chloroperoxybenzoic acid 
 
Me      methyl 
 
Me2AlCl     dimethylaluminum chloride 
 
Me2CO     acetone 
 
Me3OBF4     trimethyloxonium tetrafluoroborate 
 
MeCN      acetonitrile 
 
MeI      iodomethane 
 
MeNH2     methylamine 
 
MeOH      methanol 
 
(MeSO2)2O     methanesulfonic anhydride 
 
MHz      megahertz 
 
MgI2      magnesium iodide 
 
mL      milliliter 
 
MnO2      manganese dioxide 
 xii
 
MOM      methoxymethyl 
 
MOMCl     methoxymethyl chloride 
 
N      Normality 
 
N      nitrogen 
 
Na(Hg)     sodium-mercury amalgam 
 
NaHCO3     sodium bicarbonate 
 
Na2SO4     sodium sulfate 
 
NaBH(OAc)3     sodium triacetoxyborohydride 
 
NaBH4      sodium borohydride 
 
NaClO2     sodium chlorite 
 
NaH      sodium hydride 
 
NaIO4      sodium periodate 
 
NaN3      sodium azide 
 
NaOH      sodium hydroxide 
 
NaOMe     sodium methoxide 
 
n-Bu      normal butyl 
 
NEt3      triethylamine 
 
NH3      ammonia 
 
NMO      N-methylmorpholine N-oxide 
 
NMR      nuclear magnetic resonance 
 
N-PMBGlyME    N-PMB-glycine methyl ester 
 
O3      ozone 
 
 xiii
OsO4      osmium tetroxide 
 
P2O5      phosphorous pentoxide 
 
p-ABSA     4-acetamidobenzenesulfonyl azide 
 
Pd(OH)2/C     palladium hydroxide on carbon 
 
Pd(Ph3P)4     tetrakis(triphenylphosphine)palladium(0) 
 
Pd/C      palladium on carbon 
 
Ph      phenyl 
 
PhCH3      toluene 
 
PhSCH2CO2H     (phenylthio)acetic acid 
 
PhSeBr     phenylselenyl bromide 
 
PhSO2Na     benzenesulfinic acid sodium salt 
 
PivCl      pivaloyl chloride 
 
PLE      porcine liver esterase 
 
PMA      phosphomolybdic acid 
 
PMB      4-methoxy benzyl 
 
pyr      pyridine 
 
Rh2(cap)4     rhodium (II) caprolactamate dimer 
 
Rh2(OAc)4     rhodium (II) acetate dimer  
 
SnCl4      tin (IV) chloride 
 
SOCl2      thionyl chloride 
 
TBAF      tetrabutylammonium fluoride 
 
TBSCl      t-butyldimethylsilyl chloride 
 
 xiv
TBSOTf     t-butyldimethylsilyl 
trifluoromethanesulfonate 
 
TBTU      2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate 
t-Bu      tert-butyl 
 
TEA      triethylamine 
 
TEMPO     2,2,6,6-tetramethyl-1-piperidinyloxy 
 
TESCl      triethylsilyl chloride 
 
TFA      trifluoroacetic acid 
 
TfOH      trifluoromethanesulfonic acid 
 
THF      tetrahydrofuran 
 
Thr      threonine 
 
TiCl4      titanium (IV) chloride 
 
TMOF      trimethyl orthoformate 
 
TMSCl     trimethylsilyl chloride 
 
Tol      toluene 
 
TPAP      tetrapropylammonium perruthenate 
 
TsOH      toluenesulfonic acid 
 
 xv
 
 
 
Studies in Rhodium Catalyzed Intramolecular C-H Insertion of Amino Acid 
Derived α-Diazo-α-(substituted)acetamides and its Application to the Total 
Synthesis of clasto-Lactacystin β-Lactone 
 
David L. Flanigan Jr. 
 
ABSTRACT 
 
 
 Lactacystin is a microbial metabolite isolated by Omura that exhibits neurotrophic 
activity in neuroblastoma cell lines. Lactacystin and especially its β-lactone analog are 
the first examples of non-polypeptide small molecules capable of specifically inhibiting 
the 20S proteasome. Various asymmetric total syntheses of lactacystin and its analogs 
have been reported. The total synthesis of clasto-lactacystin β-lactone is achieved using 
L-serine methyl ester as the starting material and the sole source of stereochemical 
induction. The success of this synthesis hinges on two featured transformations. The first 
key step involves formation of the γ-lactam core via rhodium (II) catalyzed 
intramolecular C-H insertion of the α-diazo-α-(phenylsulfonyl)acetamide intermediate. 
The methodology for this transformation has been developed and applied to the synthesis 
of highly functionalized stereogenic γ-lactams from natural α-amino acids. Three control 
elements that govern γ-lactam formation are described. This step is highlighted by the 
 xvi
simultaneous creation of two stereogenic centers of the γ-lactam core. The second key 
step involves the late stage aldol coupling for quaternary carbon formation and 
installation of the hydroxyisobutyl group. In all previously reported syntheses, this is the 
very first aspect which is addressed. The stereochemical outcome of this step is directed 
by the chiral environment of the enolate itself. Various attempts to achieve selectivity are 
explored and reported. Completion of the synthesis of clasto-lactacystin β-lactone 
requires 17 steps with an overall yield of 10%. Some general attempts for optimizing the 
synthetic scheme are discussed as well as the future direction of this research.  
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Chapter One 
Introduction 
 
 
1.1 Background 
 Lactacystin (1) is a Streptomyces metabolite that was isolated and identified by 
Ōmura and initially reported in 1991.1 It has been found to be an affector of neurite 
outgrowth in mouse neuroblastoma cell line Neuro 2A.2 The scientific community was 
excited by the discovery of the first non-protein microbial metabolite to exhibit 
neurotrophic activity and three total syntheses of the new agent were reported over the 
next 3 years.3-5 Corey reported that inhibition of the cell cycle of Neuro 2A and MG-63 
human osteosarcoma cells past the G1 phase occurs upon treatment with lactacystin and 
related analogs 2-5 (Figure 1-2).6 The specific cellular target was identified by Schreiber 
α β
Figure 1-1. Schematic Diagram of  the 20S Proteasome Upon 
Inhibition by Lactacystin
Thr
Lactacystin
 2
as the 20S proteasome using tritium-labled lactacystin analogs.7 The 20S proteasome is 
the catalytic core of the 26S proteasome responsible for the degradation of denatured and 
misfolded proteins. It is also instrumental in the degradation of regulatory proteins in 
charge of cellular growth and metabolism.8  Specifically it is known to exhibit 
chymotrypsin-like, trypsin-like and peptidylglutamyl-peptide hydrolyzing (PGPH) 
activities toward small peptides.7 The 20S proteasome is an arrangement of four stacked 
rings (α- and β-units) consisting of seven protein subunits each (28 total protein subunits) 
reminiscent of a cylinder (Figure 1-1). Two threonine residues present on the β-units of 
the 20S proteasome are responsible for much of its catalytic activity.9 Lactacystin and its 
analogs have shown to affect these sites by irreversibly acylating the N-terminus of the 
threonine residues rendering them inactive.7 Schreiber’s data is confirmed by X-ray 
crystallographic analysis of the 20S proteasome deactivated by lactacystin.10,11  
 
1.2 Kinetic Inhibition Studies  
 Extensive studies concerning the structural requirements for biological activity of 
the γ-lactam were performed. The obvious alteration points for lactacystin were the C-7 
methyl, the hydroxyisobutyl group and variations of the N-acetylcysteine side chain. 
Schreiber’s initial report of the activity of lactacystin toward the 20S proteasome 
included a limited structural activity study of lactacystin (1) and related β-lactone 2, 
dihydroxy acid 3, 6-deoxy 5, 6-epi, 7-epi-lactacystin and des-hydroxybutyl lactacystin 
analogs 4 (Figure 1-2).6 Kinetic inhibition data shows that the γ-lactam core and 
stereochemistry thereof are requirements for activity of the molecule. The dramatic 
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increase in kinetic inhibition of the β-lactone intermediate implies that the electrophilic 
nature of the carbonyl governs the rate of inhibition. For instance, the dihydroxy acid 
analog exhibits no activity presumably based on the absence of electrophilic character of 
the carboxyl moiety. The β-lactone exhibits activity that is 15-fold more than that of 
lactacystin based on the increased electrophilicity of the lactone carbonyl as opposed to 
the carbonyl of the thioester. Smith preformed studies on analogs of the N-acetylcysteine 
side chain of lactacystin.12 Variations of the carboxylate function as well as deletion of 
the amide function had little effect on the activity of the analogs thus corroborating 
Schreiber’s presumption that the presence and reactivity of the C-4 carbonyl is crucial. 
Corey’s efforts toward elucidation of the ideal affector molecule focused on optimization 
of the C-7 alkyl and hydroxyisobutyl substituents of the more potent β-lactone.13 Analogs 
prepared with variations to the hydroxyisobutyl substituent involved exchange of the 
isopropyl portion of the side chain for simple alkyls and unsaturated moieties and 
NH
O
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O
S
CO2HAcHN
HO NH
O
HO
O
S
R'R
HO
6 R = NHAc, R' = CO2Allyl
7 R = NHAc, R' = H
8 R = H, R' = CO2Et
NH
O
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O
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Figure 1-2. Kinetic Inhibition Studies of Lactacystin Analogs
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specifically 9-deoxy, 9-epi and 9-keto groups (Figure 1-3). Ultimately, the 
hydroxyisobutyl side chain proved to be necessary for sufficient inhibition, that which 
was 10-fold greater than the most active analog. Eventually, X-ray studies revealed that 
the isopropyl group of the hydroxyisobutyl side chain binds was bound by a hydrophobic 
pocket of the lactacystin-labeled proteasome subunit.14 Conversely, C-7 analogs of the β-
lactone showed remarkable increase of inhibition when the methyl was exchanged for 
ethyl-, n-Bu and especially i-Pr alkyl substituents. Inhibition rates more than doubled with 
the introduction of longer alkyl chains. The 7-epi analog resulted in a decrease in activity 
reinforcing the notion that the original stereochemistry of the molecule is a requirement.  
 
1.3 Outlook 
 As the first non-protein neurotrophic factor and proteasome inhibitor, lactacystin 
has garnered much attention from both the physical and life sciences. The effects this 
small molecule exerts on living systems makes it a valuable research tool for exploration 
NH
O
O O
NH
O
R
OHO O
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R =
R
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HO H OH
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Figure 1-3. Kinetic Inhibition Studies of β-Lactone Analogs
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 5
of protein biochemistry and molecular biology. As Corey’s structure-activity project was 
submitted for publication, Adams was completing work that reported the synthesis of a 
highly active analog of lactacystin.15 A complimentary set of data supported Corey’s 
results and a β-lactone incorporating an n-Pr C-7 substituent (PS-519) was the highlight 
of Adams’ report. PS-519 went on to preclinical development by Millennium 
Pharmaceuticals for treatment of ischemia-reperfusion injury in stroke and myocardial 
infarction. The biosynthesis of lactacystin has been studied16 and more than 10 total 
syntheses of lactacystin and various analogs have been reported throughout the last 
decade. 
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Chapter Two 
Previous Syntheses 
 
 
 Newly discovered molecules usually generate interest throughout the synthetic 
community, particularly when they have novel structural scaffolds. Few synthetic targets, 
though, have demanded as much attention as lactacystin. Discovered by Omura in 1991 
while screening thousands of soil samples for differentiation of the Neuro 2A cell line, 
lactacystin’s structure was elucidated using 1H and 13C NMR techniques. The absolute 
stereochemistry was determined using single-crystal X-ray analysis. The positive 
identification of lactacystin as a potential neurotrophic factor, its appeal as a synthetic 
target and its scant supply made the γ-lactam an extremely hot target for total synthesis. 
 
2.1 Corey’s First Total Synthesis of Lactacystin 
 One year after Ōmura’s initial report, Corey published the first total synthesis of 
lactacystin.3 Starting with N-benzyl protected serine methyl ester, the amine and 
hydroxyl functionalities were simultaneously protected as the oxazolidine (10) resulting 
in a 9:1 ratio of diastereomers (Scheme 2-1). Aldol coupling of 10 with isobutyraldehyde 
utilizing the lithium bromide-lithium enolate complex yielded diastereomerically pure 11 
 7
with a 51% yield after recrystallization. The significance of this transformation lies in the 
control by which the eventual C-5 and C-9 stereocenters are formed. These seemingly 
simple transformations take advantage of the stereogenic environment indigenous to the 
enolate itself which controls the conformation of the enolate and facial approach of the 
aldehyde under non-chelated conditions resulting in formation of the quaternary C-5 
center. With the C-5 and C-9 stereocenters established, the focus turned to the formation 
of the remaining stereocenters of the lactam ring. The oxazolidine was opened up under 
acidic conditions and the resulting primary hydroxyl was protected as silylether 12. 
Again, simultaneous protection of the amine and hydroxyl functionalities with 
paraformaldehyde resulted in an oxazolidine system (13) with diminished stereochemical 
bias. The methyl ester was reduced to the primary alcohol and oxidized back to the 
aldehyde (14) using LiBH4/MeOH and Swern conditions respectively. Intermediate 14 
served as the key fragment and electrophile for the second aldol coupling. Pirrung-
Heathcock17 anti-aldol conditions resulted in a mixture of diastereomers with 78% yield 
of a 1.5:1 favorable ratio. These results were obviously disappointing and an alternative 
NBn
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Scheme 2-1. Corey's Synthesis of the First Key Lactacystin Intermediate
5
9
 8
aldol coupling using Braun’s chiral controller/Cp2ZrCl enolate conditions,18 in light of 
good diastereoselection, were not practical for gram scale reactions. Moreover, desired 
product 15 and the product resulting from attack on the opposite face of the aldehyde 
were not easily separable by column chromatography. Catalytic hydrogenation of 15 
resulted in a tandem debenzylation/cyclization sequence yielding the bicyclic γ-lactam 
(16) with C-6 and C-7 stereochemistry intact (Scheme 2-2). Deprotection of the primary 
hydroxyl yielded the diol intermediate. To avoid oxidation of both hydroxyls, selective 
oxidation of the primary hydroxyl was achieved using a two-step process. Swern 
oxidation selectively oxidized the primary hydroxyl to the aldehyde followed by mild 
sodium hypochlorite oxidation to yield acid 17. Deprotection of the N/O acetal yielded 
dihydroxy acid 3. The first total synthesis of 1 was completed by coupling the N-
acetylcysteine allyl ester with the acid functionality of 3 using BOPCl and subsequent 
deallylation with triethylammonium formate and Pd(0). Corey’s total synthesis of 
lactacystin was a 15 step protocol with an overall yield of 6%, featuring two 
N
O
HO
O
TBSO
N
O
HO
O
CO2H
NH
HO
O
CO2H
HO
NH
O
HO
O
S
CO2HAcHN
HO
NH
O
HO
O
S
CO2Allyl
OH
15
H2, Pd/C
EtOH
AcHN
i) HF, MeCN
ii) Swern Ox.
iii) NaClO2
HS(CH2)3SH,
HCl, CF3CH2OH
NHAc
CO2Allyl
HS
BOPCl
Pd(Ph3P)4
HCO2H, 
Et3N
1 6
3
17
16
Scheme 2-2. Completion of the First Total Synthesis of Lactacystin
6
7
 9
diastereoselective aldol couplings, the second which suffered from mediocre selectivity. 
Another notable feature of the synthesis is the evolution of the stereochemical elements 
of lactacystin from serine without the use of asymmetric methodologies. 
 
2.2 Corey’s Extended Methodology 
 Eventually, a follow-up to Corey’s lactacystin synthesis reported numerous 
improvements over the first, most notably of which was a superior methodology for the 
diastereoselective anti-aldol coupling as an alternative to the Pirrung-Heathcock 
conditions. A novel magnesium-catalyzed doubly diastereoselective anti-aldol coupling19 
of aldehyde 14 and the tert-butyldimethylsilyl enol ether of methyl propionate under 
Mukiyama conditions resulted in a 90% yield of 15B with no evidence of the 
corresponding diastereomer (Figure 2-1). Though Mukiyama-type open transition state 
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aldol couplings typically occur antiperiplanar, the steric repulsions illustrated above 
make the synclinal transition state a much more energetically favorable arrangement. 
 
2.3 Smith’s Total Synthesis of Lactacystin 
 Six months later a collaboration between Smith and Ōmura resulted in the second 
total synthesis of lactacystin (1).4 Touted as an easily accessible route to 1 and a variety 
of analogs, this 10-step protocol was efficient and high yielding. Starting from the 
previously prepared unnatural amino acid 2R ,3S-β-hydroxyleucine methyl ester (18), 
oxazoline derivative 19 was prepared using methyl benzimidate (Scheme 2-3). 
Utilization of this starting material circumvented the installation of the crucial and 
synthetically challenging hydroxyisobutyl side chain. A stereoselective 
hydroxymethylation of the oxazoline using LHMDS/formaldehyde resulted in 20 with 
excellent yield and diastereoselectivity (>98% de). This transformation installs the C-5 
Scheme 2-3. The Smith-Omura Total Synthesis of Lactacystin
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quaternary center with outstanding diastereocontrol. A two-step procedure including 
Moffatt oxidation of primary alcohol 20 to the corresponding aldehyde followed by 
Brown’s asymmetric allylation20 resulted in simultaneous formation of the C-6 hydroxyl 
and C-7 methyl substituents of 21 in good yield. Ozonolysis and selective oxidation of 
the resulting aldehyde yielded acid 22. Activation of the acid functionality using AcOH 
enabled spontaneous γ-lactam formation upon debenzylation of the oxazoline. 
Saponification of the ester moiety resulted in known intermediate 3. The synthesis was 
then completed utilizing Corey’s two-step protocol for esterification and deallylation. 
The highlights of the synthesis are the stereoselective hydroxymethylation and the 
asymmetric anti-allylation steps resulting in a 13% overall yield. The authors also 
implied that the synthesis is designed in such a way as to allow for minor modifications 
of the protocol providing analogs for further study. 
 Eventually, a full account of Smith and Ōmura’s work including analog synthesis 
and biological assay data was published.12 The versatility for analog synthesis lay in the 
ability of the authors to obtain the unnatural amino acid in all four isomeric forms. 
Sharpless’ asymmetric epoxidation21 provided the initial stereochemical differentiation 
from which the remainder of the synthesis evolves. The bioassay studies focused on 
analogs of the N-acetyl cysteine side chain. Though a more active analog was not 
discovered, the authors state that a less cytotoxic yet more specific agent (8) was the 
ultimate target. 
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2.4 Corey’s Expanded Studies 
 Corey’s intense intertest in lactacystin was evident during 1993 when three 
simultaneous accounts of lactacystin analog syntheses were reported.22 Perhaps the most 
significant feature of these reports was the transformation of the dihydroxy acid (3) to the 
β-lactone (2) using BOPCl as the activator for the lactonization. Initially, intermediate 3 
was part of an alternate, higher yielding sequence for incorporation of the N-acetyl 
cysteine side chain. Lactonization of 3 occurred readily and nucleophilic substitution 
with the thiol containing side-chain was also an efficient process. These analogs, in 
addition to a few others, were the subject of Corey’s structure activity relationship and 
biological assay studies that identified clasto-lactacystin β-lactone (2) as the most potent 
lactacystin analog known.6 
 
2.5 Baldwin’s Total Synthesis of Lactacystin 
 The first two total syntheses of lactacystin had similar strategies. Both syntheses 
utilize variations of Seebach’s oxazolidine/oxazoline alkylation protocol23 for formation 
of the C-5 quaternary center. The critical hydroxyisobutyl side chain was the very first 
structural and stereochemical issue addressed. Upon installation, the side chain was 
protected along with the amino functionality as a chiral oxazolidine/oxazoline from 
which the stereochemistry of the γ-lactam is derived.  
 Baldwin’s synthesis of 1 employed a chiral bicyclic γ-lactam derived from (R)-
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glutamate (23) for stereochemical induction (Scheme 2-4).24 A sequence of methylation, 
selenation and oxidation yielded the α,β-unsaturated γ-lactam (24). Aromatization to 
siloxypyrrole 25 provided a key intermediate which was eventually utilized as the silyl 
enol ether in a Mukiyama type aldol coupling. Using isobutyraldehyde as the electrophile 
and SnCl4 as the Lewis acid, the aldol coupling proceeded in only mediocre yield with a 
favorable 9:1 ratio of 26 and its C-9 epimer. Upon formation of the quaternary center, the 
secondary hydroxyl was protected through acetylation. Syn-dihydroxylation of the 
unsaturated lactam using osmylation proceeded stereoselectively via substrate control in 
good yield. Removal of the tertiary hydroxyl of the diol using Barton’s cyclic 
thiocarbonate radical methodology25 occurred in excellent yield, however, the resultant 
product was approximately a 1:1 ratio of C-6 epimers. Exposure to 0.5N NaOH resulted 
in a significant increase of the desired diastereomer (27), although substantial amounts of 
starting material (10%), epi-27 (10%) and elimination (5%) persisted. Cleavage of the 
hemiacetal using hydrogenation resulted in a mixture of epimers at C-3 (formerly C-6). 
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The one-pot global protection was achieved by sequential addition of triethylsilylchloride 
and acetic anhydride/pyridine to mask the primary and secondary hydroxyls respectively. 
Deprotection of the silyl ether and oxidation using chromic acid yielded the carboxylic 
acid which was saponified with NaOH to yield 3. The synthesis of 1 was completed using 
Corey’s method of direct addition of the N-acetylcysteine sidechain. Baldwin’s synthesis 
utilized a unique route and was similar to Corey’s first synthesis in that he relied on the 
stereochemical nature of the starting amino acid for stereochemical induction, thus using 
no asymmetric methods. Drawbacks of the synthetic route were the low yields of the 
aldol coupling and the occurance of diastereomeric mixtures in no less than three steps of 
the synthesis. Overall, Baldwin’s synthesis of 1 was achieved in 20 steps with a 4.3% 
overall yield. 
 
2.6 Chida’s Total Synthesis of Lactacystin 
 Chida’s total synthesis of 126 was novel in the sense that the three previous reports 
started with amino acid derivatives. In this particular synthesis D-glucose serves as the 
starting material and the stereogenic template. The primary and secondary hydroxyls of 
the previously prepared 3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose 
(28) were benzylated and oxidized, respectively, to the protected ketone (Scheme 2-5). 
The Wittig reaction resulted in an inseparable mixture of (E)- and (Z)-isomers (29) in a 
1:1 ratio. Reduction of the ester and reaction with trichloroacetonitrile gave the Overman 
rearrangement27 substrate, trichloroacetimidate 30. The rearrangement was preformed in 
a sealed tube by heating 30 to 150 °C in toluene for 89 hours to give terminal olefin 31. 
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The reaction gave a 60% yield of a mixture of C-5 epimers in a favorable 5:1 ratio. 
Hydrolysis of the acetonide and oxidative cleavage of the diol affected formation of the 
hemiaminal. Subsequent chromic acid oxidation gave the γ-lactam which, upon treatment 
with NaBH4, was completely deprotected yielding 32. A sequence of reactions including 
protection of the secondary hydroxyl of 32, deprotection and oxidation of the benzyl 
ether to the aldehyde and addition of isopropylmagnesium bromide resulted in a complex 
mixture of C-9 epimers and reduced primary alcohol. Chromatographic separation of the 
mixture enabled recycling of the reduced product back into the sequence. The undesired 
C-9 epimer was subject to Moffatt oxidation and selectively reduced to yield desired 
alcohol 33. Desilylation, ozonolysis and selective oxidation using sodium chlorite 
provided the common intermediate 3. As was the case with the other syntheses, Chida 
also finished the synthesis of 1 using Corey’s protocol. The novelty of this synthesis, in 
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addition to starting with D-glucose, lies in the formation of the C-5 quaternary center via 
Overman rearrangement. The three previous syntheses formed the C-5 quaternary center 
via stereoselective aldol coupling. The shortcomings of the protocol are evident not only 
in the poor selectivity of the Wittig reaction and the Overman rearrangement, but 
especially in the necessity of a sealed tube for the latter transformation. The 
rearrangement, particularly, put an original twist on the protocol but renderd it 
impractical.  
 
2.7 Corey’s Second Total Synthesis of Lactacystin 
 Corey eventually published a new, shorter, more efficient synthesis of 1 
employing a unique strategy for controlling diastereoselectivity utilizing a blocking 
group.14 This report featured an expedient construction of the γ-lactam moiety and 
installation of the isopropyl side-chain later in the synthesis to facilitate lipophilic group 
analog synthesis. The effectiveness of the blocking group itself relied on three 
requirements; (a) it had to be readily reducible, (b) it had to be sufficiently bulky to 
control the stereochemistry of the hydroxymethylation of the β-keto ester and (c) it had to 
facilitate a scalable enantioselective process. The methylsulfide blocking group was 
installed by thioalkylation of dimethyl methylmalonate giving the methylsulfanyl 
derivative 34 (Scheme 2-6). An enantioselective hydrolysis using porcine liver esterase 
gave the stereogenic monoester 35 in 62% yield and 95% ee after recrystallization. 
Exposure of the carboxylic acid to oxalyl chloride provided the stereogenic acid chloride 
which readily coupled with N-PMB-glycine methyl ester. Subsequent Dieckmann 
cyclization resulted in the cyclic β-keto ester in a 1:1 ratio of diastereomers 36. At this 
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point in the synthetic route the methylsulfide blocking group was intact, the γ-lactam 
skeleton was formed and the α-carbon of the β-keto ester was primed for aldol coupling. 
Enolization using DBU and addition of formaldehyde resulted in a 9:1 ratio of 
diastereomers which underwent stereoselective reduction of the keto moiety yielding 37 
with a 95% yield and 99% ee. The effectiveness of the methylsulfide blocking group was 
showcased in the two previous transformations for its ability to control selectivity 
through the stereogenic environment of the substrate alone without external asymmetric 
induction. Simultaneous protection and selective deprotection of the primary hydroxyl 
resulted in a silyl ether protected secondary hydroxyl and an oxidizable primary hydroxyl 
group. Diastereoselective desulfurization using Raney nickel resulted in a 10:1 ratio of 
epimers at the C-3 center. Dess-Martin oxidation of the primary alcohol to the aldehyde 
38 set the system up for nucleophilic addition of the isopropyl side-chain or other 
nucleophiles leading to potential analogs. Grignard and organolithium additions of the 
isopropyl group proceeded slowly and resulted in the retro-aldol cleavage product. The 
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use of 2-propenyl Grignard reagent in conjunction with TMSCl as an anion trap was 
efficient and the reaction occurred stereospecifically to give secondary alcohol 39 in high 
yield with no trace of retro-aldol cleavage. Corey proposed that the stereocontrol is a 
result of the steric blocking that exists when Mg2+ chelates the 1,3-dicarbonyl system. 
The completion of the synthesis involved hydrogenation of the isopropenyl group, 
desilylation of the secondary hydroxyl group and hydrolysis of the ester moiety yielding 
dihydroxy acid 40. As in previous work, BOPCl was used to affect lactonization and 
ceric ammonium nitrate oxidation of the N-PMB group yields β-lactone 2. This protocol 
touts its applicability from an economic standpoint as well as its efficiency of synthetic 
steps and isolation of pure products. An additional point is the versatility it lends to 
analog synthesis for bioassay studies. 
 
2.8 Kang’s First Formal Synthesis of Lactacystin 
 Shortly after Corey’s second generation synthesis, Kang reported two novel 
routes28 to 1, both employing an intramolecular mercurioamidation of an allylic 
trichloroacetimidate.29 The first protocol started with the base promoted ring opening of 
Sharpless epoxide 4130 followed by functionalization of the primary hydroxyl as the 
trichloroacetimidate (42) using trichloroacetonitrile and DBU (Scheme 2-7). Treatment 
of 42 with mercuric trifluoroacetate and K2CO3 resulted in mercuration of the olefin and 
concomitant oxazoline formation via intramolecular mercurioamidation. Workup using 
TEMPO and LiBH4 gave the masked hydroxyl 43. Routine protection of the secondary 
hydroxyl, deprotection of the primary hydroxyl and sequential oxidation gave oxazoline 
44. Reflux under acidic conditions followed by addition of zinc initiated oxazoline 
 19
hydrolysis, concomitant γ-lactam cyclization and cleavage of the TEMPO group. 
Protection of the cis- primary and secondary hydroxyls as the acetonide occurred 
selectively (7:1) over the gem-hydroxymethyl groups presumabley based on the 
cyclization of the fused 5,6-system (45) as opposed to the spiro system. Swern oxidation 
of the persisting primary hydroxymethyl group to the aldehyde and Grignard addition of 
i-PrMgBr resulted in a disappointing 1:1 ratio of C-9 epimers. Serendipituously, it was 
realized that with addition of excess Grignard reagent to the ester analog, the reduced 
desired product 46 was obtained exclusively. Intermediate 46 was the previously known 
trihydroxy intermediate of Baldwin’s synthesis, thus completing the first formal synthesis 
utilizing Kang’s intramolecular mercurioamidation methodology. 
 
2.9 Kang’s Second Formal Synthesis of Lactacystin 
 The second simultaneous report involved a completely original route to 1. The 
key step in the synthesis was, again, the intramolecular mercurioamidation of an allylic 
trichloroacetimidate. This time the functionality of the latent lactam is installed 
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throughout the first part of the synthesis and the key step was the endgame to 1. The 
Sharpless epoxide 47 was subjected to base promoted ring opening and the resulting 
allylic and secondary alcohols were selectively oxidized and benzoylated respectively 
(Scheme 2-8). Stereoselective crotylboration of α,β-unsaturated aldehyde 48 provided 
alcohol 49 in a 50:1 diastereomeric ratio. The resultant secondary alcohol was protected 
as the MOM ether and the terminal olefin was oxidized to the aldehyde. Exposure of the 
aldehyde to hydroxylamine hydrochloride resulted in the oxime and upon treatment with 
methanesulfonic anhydride and DBU the latent nitrile (50) was unmasked. Hydrolysis of 
the benzoyl protecting group and functionalization with trichloroacetonitrile resulted in 
trichloroacetimidate 51. The key step of this synthesis is initiated by addition of mercuric 
acetate to the olefin of 51. Spontaneous cyclization to the oxazoline gives a mixture of 
separable diastereomers, the desired mercurate in 64%. As in the previous synthesis 
problematic oxidative demercuration issues were circumvented by exposing the 
oxazoline to LiBH4/TEMPO providing 52. Exposure to 6N HCl followed by AcOH 
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hydrolyzes the oxazoline, initiates cyclization and removes the TEMPO group resulting 
in the known triol 46. Overall, both of Kang’s syntheses of 1 rely on Sharpless 
asymmetric epoxidation early in the synthetic scheme and utilize the intramolecular 
mercurioamidation of a trichloroacetimidate to set up a zinc promoted cyclization to the 
γ-lactam.  
 
2.10 Adams’ Total Synthesis of Lactacystin Analog PS-519 
 Lastly, Adams’ team at LeukoSite conducted an independent synthesis and 
structure activity study of 2 and its analogs. Confirming and building upon Corey’s data, 
Adams found that increasing the bulk of the C-7 alkyl substituent the activity increases 2-
fold. Ultimately, the group settled on the n-propyl C-7 substituent/β-lactone combination 
to give them the best activity and labled the experimental compound PS-519. The novelty 
of this synthesis lies in the use of a semi-convergent route. All other syntheses to date 
have been strictly linear routes based on the compact nature of 1 and 2. The key step of 
the synthesis is the convergence of a stereogenic aldehyde and a trans-oxazoline via a 
Scheme 2-9. Synthesis of the trans-Oxazoline Coupling Partner
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doubly diastereoselective aldol coupling. The construction of the oxazoline fragment 
begins with Sharpless’ asymmetric dihydroxylation31 of the Wittig product of 
isobutyraldehyde and methyl-triphenylphoranylideneacetate (53). The quatitative 
conversion to diol 54 occurred with only 77% ee but was improved to >99% ee after 
recrystalization. Upon addition of trimethyl orthobenzoate the diol was tied up as the 
cyclic orthoester and subsequently opened with the addition of acetylbromide resulting in 
the bromohydrin 55. Azide 56 is the product of bromide displacement and hydrogenation 
yields amine 57. Refluxing in toluene with toluenesulfonic acid provided stereogenic 
oxazoline 58 that would ultimately provide the hydroxyisobutyl and C-5 portions of PS-
519. The coupling partner of 58 is a chiral α-alkyl-β-formyl amide that will provide the 
chelation control for the doubly diastereoselective aldol coupling. The coupling fragment 
is derived from acyloxazolidinone 59 (Scheme 2-10). Alkylation of the titanium enolate 
using benzyloxymethyl chloride gave oxazolidinone 60 which, after peroxide hydrolysis, 
yields the carboxylic acid 61. Transformation of the acid to the diethyl amide 62 was 
achieved using triethylamine and TBTU to add diethylamine. Hydrogenolysis of the 
benzyl ether yielded the hydroxy amide (63) which, upon exposure to Dess-Martin 
Scheme 2-10. Synthesis of the α-Alkyl-β-formyl Amide Coupling Partner
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oxidation conditions resulted in the α-alkyl-β-formyl amide (64) coupling partner. After 
exploring a multitude of conditions for the aldol coupling of 58 and 64, it was determined 
that enolization of the oxazoline and sequential addition of dimethylaluminum chloride 
followed by the aldehyde gave the 6S alcohol (65) exclusively. The stereochemical 
rationale was explained using the transition state model shown in Figure 2-2. Chelation 
of the 1,3-dicarbonyl system of 64 by the Lewis acid requires the n-propyl substituent to 
adopt a si-face blocking position. This leaves only approach from the re-face possible in 
anti-Felkin-Ahn-Eisenstein fashion.32 While the stereochemistry of C-6 was a direct 
result of the chelation model, the C-5 stereochemistry is purely based on steric bias of the 
isopropyl substituent of the oxazoline. Apart from obtaining alcohol 65 exclusively, the 
significance of this transformation lies in the use of a dialkylaluminum chloride as a 
Figure 2-2. Stereochemical Rationalization of Adams' Doubly Diastereoselective Aldol Coupling
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bidentate Lewis acid as opposed to its typical utility as a monodentate coordinator. With 
alcohol 65 in hand, three routine transformations remained to complete the synthesis of 
PS-519 (Scheme 2-11). As seen in previous syntheses, hydrogenolysis of the oxazoline 
initiates spontaneous cyclization to the γ-lactam 66 which was recrystalized and 
structurally confirmed using X-ray diffraction analysis. Saponification of the methyl ester 
using NaOH yielded dihydroxy acid 67 which was then activated by conversion to the 
mixed anhydride using isopropenyl chloroformate. Subsequent cyclization resulted in β-
lactone 9, an analog of the highly potent β-lactone 2. Adam’s synthesis of 9 was also 
applied to the total synthesis of 2 using a parallel method with only slight variations in 
starting material preparation. This particular synthesis is highlighted by a semi-
convergent protocol requiring 10 operations resulting in a 20% overall yield of 9 starting 
from readily available oxazoline 58. 
 Overall, lactacystin (1) and its various analogs have garnered much attention 
based not only on the pharmacological significance of the target but on the synthetic 
challenges they present. The syntheses above are the premier works preformed on this 
family of molecules and do not include the many unsuccessful attempts or works in 
progress that have not yet been reported. 
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Chapter Three 
Stereogenic γ-Lactams via Rhodium Catalyzed Intramolecular C-H Insertion 
 
 
 Of the many natural products that possess γ-lactam cores,33 lactacystin (1) and its 
intermediates are quite possibly the most outstanding in terms of biological activity, 
structural originality and synthetic appeal. The β-lactone (2) is particularly intriguing 
based on its bicyclic [3.2.0] arrangement, four contiguous stereogenic centers (one a 
quaternary center) and high concentration of heteroatoms. Considering the methodologies 
we developed, 2 appeared to be an ideal synthetic target for its validation. In all previous 
syntheses of 1 and its analogs the strategy is to asymmetrically functionalize a linear 
molecule followed by formation of the γ-lactam by nucleophilic addition of an amine 
moiety to an activated ester. Our proposed synthesis involved γ-lactam formation via 
rhodium catalyzed intramolecular C-H insertion followed by stereoselective 
functionalization of the γ-lactam core. 
 
3.1 C-H Insertion of the Acyclic System 
 Our first tier of this methodology originated from our discovery of rhodium catalyzed 
intramolecular C-H insertion of α-diazo-α-(phenylsulfonyl)acetamides to give γ-lactams 
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regio- and stereoselectively.34 Previous work showed that this general transformation, 
when applied to α-amino acid derivatives, typically resulted in mixtures of β- and γ-
lactam regioisomers.35 Padwa and Wee reported that the ratios of the regioisomers could 
be affected by the electronic nature of the carbenoid α-substituent.35d,e Our model system 
utilizes an α-phenylsulfonyl substituent for alteration of the electron density of the 
metallocarbenoid and also exerts a steric effect for enhancement of regio- and 
stereoselectivity. The showcase example of this transformation from the α-diazo-α-
(phenylsulfonyl)acetamide to the trans-γ-lactam is shown in Scheme 3-1. Reflux 
conditions using rhodium acetate dimer provide the γ-lactams exclusively in excellent 
yield with no β-lactam or aromatic cycloaddition side products. Rationalization of the 
regio- and stereochemical selectivitiey is shown in Scheme 3-2. The first control element 
of this transformation is the conformational effect. Rhodium carbenoid 70 can adopt the 
s-cis and the s-trans conformations. The s-cis conformer is favored due to the severe 
nonbonded interaction between the t-butyl substituent and the rhodium ligands that exist 
in the s-trans conformer. As a result of the conformational effect, two possible transition 
states exist through which insertion can occur. Reaction via 5-membered transition state 
71 and 6-membered transition state 72 would yield β-lactam 73 and γ-lactam 74 
respectively. Padwa and Doyle performed similar transformations using the α-acetyl 
Scheme 3-1. Rhodium Catalyzed Intramolecular C-H Insertion of α-Diazo-α-(phenylsulfonyl)acetamides
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substituent with various rhodium catalysts.35e All attempts resulted in mixtures of β- and 
γ-lactam with no ratio of regioisomers exceeding 3:7 respectively. In the same report it 
was proposed that when a catalyst with an electron donating ligand is used the rhodium 
carbenoid is stabilized thus proceeding through a late transition state.36 As shown by the 
results, when the α-phenylsulfonyl substituent is incorporated into the insertion precursor 
we achieve complete selectivity for the γ-lactam. Presumably, the α-phenylsulfonyl 
substituent lends further stabilization to the carbenoid allowing the cyclization to occur 
via 6-membered transition state exploiting the stereoelectronic effect. Also explained by 
the transition state is the trans- geometry at C-3 and C-4. For insertion to occur the 
carbon-rhodium “bond” and the target C-H bond must be arranged parallel to each other. 
Two conformations exist since insertion is occurring at a methylene center. The more 
favorable conformation in this case is that in which the C4/C5 bond is oriented so that the 
phenyl substituent is in the pseudoequitorial position resulting in trans-γ-lactam 74.37 The 
outstanding selectivity of this transformation makes it an attractive method of 
Scheme 3-2. Conformational and Stereochemical Effects on C-H Insertion
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constructing γ-lactams. 
 
3.2 C-H Insertion of the Cyclic System 
 In an attempt to expand the general applicability of this methodology we considered 
utilizing amino acids as highly versatile, stereogenic substrates. To our surprise an 
extensive literature search revealed that previous attempts using amino acids as C-H 
insertion substrates were unsatisfactory due to poor regio- and stereoselectivities and side 
reactions.38 With an original approach, our methodology was modified to accommodate 
amino acid derived precursors for the synthesis of highly functionalized chiral γ-
lactams.39  
 Synthesis of the prototype phenylalanine derived α-diazo-α-
(phenylsulfonyl)acetamide 77 began with esterification of the acid function of (L)-
phenylalanine followed by amide coupling using (phenylthio)acetic acid resulting in 
amide 75 (Scheme 3-3). Reduction of the methyl ester using LiBH4 generated in situ gave 
the primary alcohol. With protection of the alcohol and amide moieties as our focus, we 
sought to simultaneously tie-up both functional groups as acetonide 76. In toluene, the 
Scheme 3-3. Synthesis Stereogenic γ-Lactams From α-Amino Acid Precursors
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alcohol was refluxed with 2,2-DMP and catalytic TsOH. A Dean-Starke apparatus was 
instrumental in water removal. This particular transformation was quite disappointing 
based on the inconsistency of product yield and side reactions that occurred. After a 
tedious purification using silica gel column the phenylsulfide was completely oxidized to 
the phenylsulfone using multiple equivalents of m-CPBA. Finally, the α-position was 
activated for carbenoid formation by installation of a diazo group using Davies’ p-ABSA 
reagent and DBU yielding 77. Intramolecular C-H insertion occurs efficiently under 
reflux in methylene chloride with a catalytic amount of rhodium acetate dimer. This 
transformation provides the trans-γ-lactam 78, as a single diastereomer, in excellent yield 
without formation of β-lactam or aromatic cycloaddition products. The regio- and 
stereoselectivity of this cyclization is explained using a modified transition state theory 
congruent to our aforementioned acyclic system and control elements previously 
discussed (Scheme 3-4). Metallocarbenoid 79 adopts the favorable s-cis conformation as 
dictated by the conformational effect. Based on the severe nonbonded interaction 
Scheme 3-4. Conformational and Stereochemical Effects on C-H Insertion of α-Amino Acid Derivatives
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between the rhodium ligands and the gem-dimethyl moiety of the acetonide, s-trans-79 is 
the unfavorable conformation. Insertion then occurs via the 6-membered transition state 
(81) as directed by the stereoelectronic effect and proven by the absence of β-lactam 
formation. The trans-stereochemistry of the γ-lactam is established by the preference of 
the C-4 substituent to orient itself in the pseudoequatorial position, thus relieving the 1,3-
diaxial interaction present in transition state 80. The profound significance of the 
conformational effect is exemplified by attempting to perform C-H insertion on an analog 
of 77 that has a formaldehyde derived acetal (82) in place of the acetonide (Scheme 3-5). 
The s-trans 83 conformation of the amide is more favored in the presence of the 
methylene group. In this case, the typical insertion center is oriented away from the 
rhodium carbenoid, therefore, no insertion occurs. 
 Intramolecular C-H insertion of the (L)-phenylalanine derivative resulted in γ-lactam 
78 as a single enantiomer whose stereochemistry was governed by the existing 
stereocenter of the original amino acid. The stereochemistry of the γ-lactam (78) was 
confirmed by X-ray crystallographic analysis. Ultimately, two new stereocenters are 
formed in a single synthetic operation providing highly versatile, functionalized, 
stereogenic γ-lactams selectively. 
 
Scheme 3-5. Conformational Requirements for Intramolecular C-H Insertion
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3.3 C-H Insertion of Amino Acid Derived α-Diazo-α-(phenylsulfonyl)acetamides 
 With a highly effective protocol for converting (L)-phenylalanine into a highly 
functionalized stereogenic γ-lactam in hand, we decided to apply it to a series of α-amino 
acids. It is well established that the trend for preference of C-H insertion to occur at a 
particular center is methine>methylene>methyl. The electron deficient carbenoid carbon 
complexes with the most electron rich C-H bond via the 6-membered transition state and 
insertion immediately ensues. The substrates were specifically chosen to examine our 
stereoelectronic and substituent effect hypotheses by containing multiple insertion sites 
and varying degrees of electron donating and withdrawing substituents, respectively. 
Table 3-1 shows the results of C-H insertion on α-amino acid derived α-diazo sbstrates 
with various alkyl substituents and multiple potential insertion centers. In most cases the 
γ-lactam was formed exclusively and in high yield. Entries 1 and 2 are perfect examples 
of the influence that the stereoelectronic effect has on the course of the reaction. With 
Table 3-1. C-H Insertion of α-Diazo Substrates at the Methylene Position
N
R
O
PhSO2
O
N2
N
O
O
PhSO2
R H
Rh2(OAc)4
CH2Cl2, reflux
entry R reactant yield (%) product
1
2
3
4
5
6
Me
Et
i-Pr
Bn
CH2CO2Me
4-(MeO)Ph
87
92
87c
87
64
86
Ph7 91
84a 85
86a 87
88b 89
90a 91
92 93
94d 95
77 78
a Starting with the corresponding racemic α-amino acid. b Rh2(pfb)4 was 
used. c δ-lactam was also obtained (6%). d Starting with 4-methoxytyrosine.
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two electronically similar methylene centers present on the ethyl (84) and propyl (86) 
alkyl chains as the possible insertion sites, the stereoelectronic effect dictates the 
formation of the γ-lactam in favor of the β-and δ-lactams. Entry 3 shows the preference 
for insertion to occur at a methine center. Though insertion at the methylene center of the 
isobutyl (88) side chain provides the γ-lactam in high yield, six percent of δ-lactam is 
formed as well. In comparison, the only difference that exists between the analogs is the 
presence of a methine center in 88 as opposed to an additional methylene center in 86. In 
the case of 86 no δ-lactam is formed and it can be concluded that the stereoelectronic 
effect dictates γ-lactam formation exclusively. However, the preference for insertion at a 
methine center is significant enough to provide the δ-lactam, albeit as the minor product. 
The goal of entries 4 and 6 were to compare the results of insertion on analogs of our 
showcase example (entry 7). Presumably, the facile conversion of 77 to 78 was enhanced 
by the phenyl substituent directly adjacent to the methylene center. Incorporation of an 
additional methylene center to the insertion precursor (90) had no effect on the 
transformation and only γ-lactam was formed. In an attempt to enhance the 
transformation of 77 to 78, a tyrosine analog with an electron donating 4-methoxy 
substituent was derived (94). No appreciable improvement was noticed in the reaction in 
light of the modest increase in electron density. α-Diazo amide 92 is an (L)-glutamic acid 
derivative that possesses an electron withdrawing carbomethoxy group. This reaction 
proceeded with only a moderate yield as a result of the decreased reactivity of the 
insertion center. This particular reaction was intriguing since there was no β-lactam, δ-
lactam or ylide formation detected and no starting material recovered. The γ-lactam was 
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the only product recovered and the other side products were indecipherable. A series of 
analogs with potential methyl and methine insertion centers were also subject to our 
methodology (Table 3-2). α-Diazo amide 96 derived from (L)-alanine underwent 
intramolecular C-H insertion to yield γ-lactam 97 exclusively, though only in moderate 
yield. Insertion into the methyl C-H is an unfavorable process especially in the presence 
of a methine center from which the β-lactam would form. This example corroborates the 
strong influence that the stereoelectronic effect exerts on this transformation. In entries 2 
and 3 both insertion precursors possess methine centers from which the γ-lactam, via C-H 
insertion, will potentially form. C-H insertion of α-diazo amides 98, an (L)-valine 
derivative, and 100, an (L)-isoleucine derivative, both proceeded with excellent yield and 
result in exclusive γ-lactam formation (99 and 101 respectively) as anticipated. 
Disastereomeric mixtures were formed in both cases. This is a result of the substituents at 
the methine centers having no significant steric bias (two methyls in the case of (L)-
valine and a methyl and an ethyl in the case of (L)-isoleucine) to achieve a particular 
conformation at the insertion center. A point of note is that upon desulfonation of 101 
using Na(Hg) a single diastereomer (102) was recovered which suggests that the insertion 
Table 3-2. C-H Insertion of α-Diazo Substrates at Methyl and Methine Postitions
N
O
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PhSO2
H
Rh2(OAc)4
CH2Cl2, ∆
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3
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proceeds with complete retention of configuration of the inserton center. In light of the 
success of methylene insertion we attempted insertion of electronically activated 
methylene centers. A set of α-amino acid derivatives that were suitable for this 
transformation were those of (L)-serine (103) and two different (L)-threonine analogs 
(105 and 107) (Table 3-3). We anticipated an enhancement in efficiency of insertion into 
the methylene C-H adjacent to a heteroatom due to electronic inductive effects. As 
expected, the efficiency of insertions were improved as yields were comparable with data 
from methine C-H insertions. Entries 1 and 2, which possessed essentially identical 
insertion sites, both proceeded with excellent yield and resulted in exclusive trans-γ-
lactam formation. The alternate (L)-threonine derivative 107 also underwent C-H 
insertion in high yield but resulted in a diastereomeric mixture of γ-lactams at the C-3 
Table 3-3. C-H Insertion of α-Diazo Substrates at Electron Rich Methylene Positions
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Scheme 3-6. Functionalized Stereogenicγ-Lactams are Versatile Synthetic Intermediates
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position as experienced previously with the (L)-valine and (L)-isoleucine derivatives. 
Presumably, the steric bias of the methyl group rivals that of the tert-butyldimethylsilyl 
ether since the bulk of the substitution on the silicon is one oxygen atom removed from 
the reaction center. Nevertheless, insertion at the chiral center of the side-chain of (L)-
threonine results in retention of configuration. Moreover, the success of insertion at the 
methylene position adjacent to a heteroatom adds a degree of functionality to the γ-
lactam. An intriguing point and an impetus for further pursuit and application of this 
methodology is the striking resemblance that γ-lactams 104 and 108 have with synthetic 
targets 1 and 109, and it is, therefore, anticipated that they will be valuable synthetic 
intermediates (Scheme 3-6). In general this methodology is useful for the synthesis of 
highly functionalized γ-lactams from stereogenic α-amino acids. In one synthetic 
operation, two additional chiral centers are formed in a stereoselective fashion and result 
in γ-lactams that are functionalized at each carbon center. 
 
3.4 C-H Insertion of α-Diazo-α-(substituted)acetamides 
 The success of C-H insertion of α-amino acid derivatives encouraged us to explore 
alternate pathways for diversified functionality and a streamlined synthetic sequence. Our 
initial route for construction of the α-diazo-α-(phenylsulfonyl)acetamides derived from 
α-amino acids was relatively costly, suffered from yield inconsistency and required 
multiple laborious purification steps. Particularly, the acetonide formation step, which 
involved tying-up the amide nitrogen and the primary alcohol, was impetuously 
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inconsistent. Side products, incomplete cyclizations and a rather formidable flash column 
purification rendered this process impractical. An improved sequence that was one 
synthetic operation shorter, utilized commodity reagents and required no purification, 
until after the diazotransfer step, was formulated. The new protocol called for the 
reduction of the (L)-phenylalanine using lithium aluminum hydride to provide the 
corresponding amino alcohol (Scheme 3-7). The Fischer protocol was utilized to complex 
and precipitate the unreacted LAH as a means of filtering the product and avoiding the 
use of aqueous work-up procedures. A superior procedure for acetonide formation 
involved refluxing the amino alcohol in a 1:1 mixture of 1,2-DCE and acetone with the 
addition of Na2SO4 as a water scavenger. This reaction was complete in less than one 
hour and simple filtration of the solids followed by evaporation of the solvent provided 
acetonide 110 cleanly in near quantitative yield. This improved protocol also provided 
options for functionalization of this system. The secondary amine, in this case, could be 
Scheme 3-7. Improved Synthetic Protocol for Analog Synthesis
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easily acylated using a variety of reagents. Toward obtaining our α-diazo-α-
(phenylsulfonyl)acetamide intermediate, a three-step procedure consisting of N-acylation 
using bromoacetyl bromide followed by bromide displacement with benzenesulfinic acid 
sodium salt proceeded cleanly and in very good yield providing the known 
phenylsulfonyl intermediate (77). With our goal of highlighting the profound effect that 
the α-phenylsulfonyl substituent plays in γ-lactam formation via C-H insertion, a series 
of α-diazoacetamide analogs with α-substituents of varying electron-withdrawing 
capacities were prepared. The three variations used to contrast to the α-phenylsulfonyl 
substituent were the α-ethoxycarbonyl, α-acetyl and, simply, α-diazo substituents (Table 
3-4). Our improved protocol for synthesis of the α-substituted acetamides was applied 
and construction of the three analogs was possible from acetonide 110. N-acylation using 
ethyl-4-chloroacetoacetate and diketene afforded the α-ethoxycarbonyl 111 and α-acetyl 
112 acetamides respectively in high yield with no need for purification. Diazotransfer of 
both 111 and 112, although occurring at a decreased rate as compared to the α-
phenylsulfonyl acetamides, proceeds in very high yield. Analog 113, which possessed a 
proton as the α-substituent, is a product of base promoted decarbonylation of 112 using 
Table 3-4. C-H Insertion of α-Diazo Substrates with Varied α-Substituents
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LiOH in aqueous media. In anticipation of consistent results with previous reports which 
showed poor stereo- and regioselectivities, we were surprised to find that trans-γ-lactam 
formation was the exclusive product of C-H insertion with exception to the α-diazo 
substrate 113. Cyclization of 111 and 112 occurred efficiently and in very high yield 
providing chiral γ-lactams 114 and 115 with functionality that is more versatile than the 
phenylsulfone substituent. α-Diazo substrate 113, when subjected to insertion conditions, 
resulted in aromatic cycloaddition yielding cycloheptatriene 116. The latter result was 
not at all surprising and is, in fact, quite common when aromatic systems are in the 
presence of carbenes. The peculiar aspect of this data is the complete selectivity of the 
transformations. We expected a certain degree of β-lactam formation and obtained 
exclusively γ-lactam. In the case of the α-Diazo substrate 113, we expected a mixture of 
products including γ-lactam, but recovered the aromatic cycloaddition product 
exclusively. The obvious explanation for this data is the absence of an electron-
withdrawing α-substituent. Padwa and Doyle have shown, using competition 
experiments, that the rhodium catalyst ligands play a major role in reaction preference.35e 
Therefore, in an attempt to switch the preference in reactivity from aromatic 
cycloaddition to γ-lactam formation, we used the rhodium caprolactamate catalyst which 
has a more electron donating ligand. Under these conditions the reaction yielded mostly 
Scheme 3-8. Pathway for C-H Insertion of α-Diazo Substrates Resulting in Aromatic Cycloaddition
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aromatic cycloaddition product 116 along with a minor product that was eventually 
elucidated as the norcaradiene tautomer (117) of the major product (Scheme 3-8). Two 
explanations for the persistence of aromatic cycloaddition in the absence of an α-
substituent have appeared in the literature. Wee suggests that the electronic differences of 
the α-substituents dictate the reaction pathway and, in the case of the α-diazo substrate, 
preference for aromatic cycloaddition dominates.35d Padwa and Doyle reason that 
conformational influences of the α-substituents (other than α-diazo, of course) inhibit the 
approach of the phenyl group to the reactive carbene center.35e This theory is further 
corroborated by the fact that highly electron rich phenyl rings, as in the case of 
dimethoxy phenyl groups, do not undergo aromatic cycloaddition despite their increased 
vulnerability to carbene attack.40 
 Overall, our methodology is an improvement over previous methodologies based on 
the regio- and stereoselectivities obtained from C-H insertion. It was originally assumed 
Scheme 3-9. Conformational Constraint of the CyclicSystemInhibits β-Lactam Formation
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that the α-phenylsulfonyl group was responsible for the selectivity of the methodology, 
and it is most definately the case with our initial, acyclic example. Clearly, it is not the 
only factor in play since comparable success was observed in the presence of the α-
ethoxycarbonyl and α-acetyl substituents. Our latest rationalization is that the acetonide 
moiety present in all of the amino acid derived systems must play a significant role in 
lending a degree of conformational constraint to the transition state of the transformation. 
The aromatic cycloaddition product is not observed when electron withdrawing groups 
are present and the unfavored 5-membered transition state (119) required for β-lactam 
formation would experience severe non-bonded interactions. With this particular system 
used for C-H insertion of α-amino acid derivatives γ-lactams are the only likely product 
(Scheme 3-9). 
 At this point the phenyl group had participated in the reaction and had a substantial 
Scheme 3-10. Synthetic Protocol for Norvaline Analog Synthesis
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influence on the results. To dispel any skepticism about the success of this project we 
applied the same methodology to an amino acid system that included an n-propyl side 
chain. In this case multiple equivalent insertion sites were available without the influence 
of the phenyl group. We initiated this leg of the project with the racemic, unnatural amino 
acid norvaline. The improved protocol for synthesis of the C-H insertion precursors was 
applied to  the construction of the norvaline analogs (Scheme 3-10). Reduction of the 
amino acid with LAH followed by acetonide formation yielded versatile intermediate 
123. Next, the diversification using the various N-acylation conditions was carried out 
followed by diazo transfer resulting in insertion precursors 86, 124 and 125. Deacylation 
of 125 using aqueous LiOH provided α-diazo substrate 126. Exposure of the 
diazosubstrates to the standard C-H insertion conditions yielded γ-lactams in all cases 
(Table 3-5). In the case of the α-phenylsulfonyl (86), α-methoxycarbonyl (124), and α-
acetyl (125) compounds, insertion occurred with complete regio- and stereoselectivity. 
Yields were all very good and no minor products were detected. On the other hand, α-
diazo substrate 126 formed a mixture of products with very good yield but, in only a 2:1 
ratio which were separated and identified as the δ- and γ-lactams respectively.  
Table 3-5. C-H Insertion of α-Diazo Norvaline Derivatives
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a Product ratio was 2:1 favoring the δ-lactam
 42
3.5 C-H Insertion of a Conformationally Constrained Cyclic System 
 An additional series of analogs were prepared that had a varied cyclic system 
incorporated into the insertion precursors (scheme 3-11). The N,O-acetonide that was 
utilized throughout all of the previous work was replaced with an N,N’-acetonide in 
which both nitrogens were of the secondary amide type. The goal was to probe the effects 
of a more rigid cyclic system on the course of insertion. The replacement of an sp3 
hybridized center with an sp2 hybridized center would provide the increase in rigidity we 
sought. Starting from (L)-phenylalanine, esterification followed by amide formation 
using methylamine resulted in the α-amino amide, which, upon exposure to refluxing 
acetone/1,2-DCE in the presence of Na2SO4, was transformed to the N,N’-acetonide 131. 
Acylation followed by diazo transfer using conditions previously delineated achieved 
construction of the α-phenylsulfonyl-, α-ethoxycarbonyl- and α-acetyl-diazo substrates 
132, 133 and 134 respectively. Our typical C-H insertion conditions yielded γ-lactams in 
Scheme 3-11. Synthesis of N,N'-Acetonide Substrates with Varied α-Substituents
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all cases in excellent yield, regio- and stereoselectively (Table3-6). In general, a 2-6% 
increase in yield of C-H insertion of the N,N’-acetonide analogs over the N,O-acetonide 
system was obtained. This was attributed to the increase in rigidity of the N,N’-acetonide 
system over the N,O-acetonide and the marginal boost in conformational constraint that it 
lends to the transition state of the transformation.  
 After an extensive review of the literature, there seems to be no clear-cut 
rationalization concerning the effects of α-substituents on C-H insertion. Conversely, 
extensive work has been done describing the diversity of this chemistry when the catalyst 
ligands are varied. The presently accepted transition state theory for C-H insertion 
implies that the selectivity of the reaction depends on the electrophilicity of the carbenoid 
itself. Highly electrophilic, more reactive carbenes proceed via an early transition state 
resulting in decreased selectivity. Therefore, greater selectivity can be achieved by using 
a less reactive carbenoid system, namely the carbene intermediate from rhodium acetate 
or any other catalyst ligand that is not electron withdrawing in nature. One would then 
assume that electron withdrawing α-substituents would increase the reactivity of the 
carbene and make the C-H insertion process less selective, but this is just not the case. As 
Table 3-6. C-H Insertion of Confomationaly Contrained Ν,Ν-Acetonide Substrates with Varied α-Substituents
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seen in our initial acyclic example of C-H insertion of α-diazo-α-
(phenylsulfonyl)acetamides, the excellent regioselectivity is a result of the electron 
withdrawing α-phenylsulfonyl substituent. It is clear that the selectivity of the amino acid 
methodology is not based solely on the mitigating effects of the α-phenylsulfonyl 
substituent since excellent selectivity is achieved with other α-substituents as well. The 
conformational constraints exerted by the acetonide moiety must, therefore, influence the 
regioselectivity and most likely enhance the overall success of the transformation. The 
premise that the acetonide moiety plays a significant role in this transformation is 
corroborated by an alternate cyclic system that was used. The increased rigidity of the 
N,N’-acetonide system does result in an increase in the efficiency of the tansformation. 
Overall, carbenoid insertions are complex transformations that have various possible 
reaction pathways and outcomes that can be tuned by variation of catalyst ligands and α-
substituents. What we have elaborated is the formation of γ-lacams in a regio- and 
stereoselective manner from α-amino acids utilizing a variety of α-substituents. The 
utility of this methodology is directly applied to natural product synthesis of γ-lactam 
containing targets. 
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Chapter Four 
Jung’s Total Synthesis of clasto-Lactacystin β-Lactone 
 
 
 Early on in the development of our rhodium catalyzed intramolecular C-H 
insertion methodology, we discovered just how promising and effective this 
transformation was. The applicability of our initial, acylic methodology was profoundly 
broadened by its adaptation to accommodate α-amino acids as starting materials.39 Using 
only the α-amino acid as the source of stereogenic bias, γ-lactams were synthesized 
regio- and stereoselectively yielding a single enantiomer. Two additional stereocenters 
were formed simultaneously as dictated by the original stereocenter of the starting 
material and the three control elements delineated in chapter three. Immediately, we 
turned our full attention to the total synthesis of clasto-Lactacystin β-Lactone (2). 
 
4.1 Retrosynthetic Analysis of clasto-Lactacystin β-Lactone 
 We had taken notice that application of this methodology to (L)-serine yielded a 
highly functionalized γ-lactam that possessed many of the characteristics of 2. 
Retrosynthetically, we envisioned an expedient route to the target molecule featuring two 
key steps (Scheme 4-1). β-Lactone 2 is readily available via lactonization of the cis-
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arranged, masked hydroxyl and acid functionalities of intermediate 138. The alcohol 
derivative of 138 is the product of the second key step of the synthesis, namely a 
quaternary carbon-forming late stage aldol-coupling of the iminoether 139 and 
isobutyraldehyde. The iminoether is derived from γ-lactam 140. The bicyclic γ-lactam is 
a product of our rhodium catalyzed intramolecular C-H insertion of α-amino acid derived 
α-diazo-α-(phenylsulfonyl)acetamides methodology which is the first key step in the 
synthetic route. The α-diazo insertion precursor 143 is efficiently derived from (L)-
serine. 
 
4.2 First Generation Synthesis of the Bicyclic γ-Lactam Intermediate 
 Our initial endeavor into the synthesis of 2 began with the natural α-amino acid 
(L)-serine (Scheme 4-2). Esterification of the amino acid was conducted by bubbling HCl 
gas into a methanolic suspension of (L)-serine. (Phenylthio)acetic acid was then 
dissolved in methylene chloride and activated using the carbodiimide reagent DCC. 
Scheme 4-1. Retrosynthetic Analysis of the Total Synthesis of clasto-Lactacystin β-Lactone
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Addition of the HCl salt of serine methyl ester and triethylamine resulted in amide- 
coupling of amide 142. The primary alcohol and the amide nitrogen were then 
simultaneously protected as the acetonide by refluxing 142 in toluene with 2,2-DMP and 
p-TsOH yielding ester 143 (Scheme 4-3). For this transformation to occur effectively, 
removal of water using a Dean-Starke trap was required to yield the desired products. 
This particular reaction provided inconsistent results due to extensive side-product 
formation and incomplete cyclizations. The impracticality of this transformation was 
compounded by the necessity of a tedious purification via flash column chromatography. 
Nevertheless, the ester function of the recovered phenylsulfide (143) was reduced to the 
primary alcohol 144 using LiBH4 generated in situ from excess equivalents of NaBH4 
and LiCl in a 1:1 solution of THF and methanol. Protection of the hydroxyl as the silyl 
ether 145 using TBSCl and imidazole in DMF occurred in high yield. Complete 
oxidation of phenylsulfide 145 using excess m-CPBA yielded phenylsulfone 146 in 
nearly quantitative yield (Scheme 4-4). Diazo transfer using p-ABSA and DBU provided 
Scheme 4-2. Amide Coupling of (L)-Serine Methyl Ester
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the α-diazo-α-(phenylsulfonyl)acetamide insertion precursor 103. Our standard 
conditions for rhodium catalyzed intramolecular C-H insertion were carried out and the 
trans-bicyclic γ-lactam 104 was the sole product of the transformation. As one of the key 
steps of the synthetic route to 2, the γ-lactam was produced in 97% yield as a single 
enantiomer. This highly effective methodology provides γ-lactams with two additional 
stereocenters in one synthetic operation in a regio- and stereoselective manner.  
 
4.3 Functionalization of the γ-Lactam Core 
 The goal of the next leg of the synthesis was to functionalize the γ-lactam at the 
C-3 and C-5 positions. Meyers has shown that alkylations of bicyclic systems typically 
occur on the β-face (convex face in this case) of the molecule. In our bicyclic system the 
C-3 position is highly activated for alkylation. Methylation of this center using 
iodomethane and sodium hydride in DMF occured at 0 °C. Elimination of the protected 
Scheme 4-4. Intramolecular C-H Insertion of the (L)-Serine Derived α-Diazo-α-(phenylsulfonyl)acetamide
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secondary C-4 hydroxyl substituent was a competing pathway that was ultimately 
inhibited by performing the reaction at -20 °C (Scheme 4-5). The methylation of the 
bicyclic system occurred stereoselectively in nearly quantitative yield (147). This 
particular reaction benefits from the concave/convex nature of the bicyclic γ-lactam. We 
then turned our attention to hydrolysis of the acetonide followed by oxidation of the 
resulting primary alcohol in preparation for the aldol coupling of the hydroxyisobutyl 
side-chain. To circumvent reactivity issues with the silyl ether protecting group 
throughout the remainder of the synthesis, the protected secondary hydroxyl 147 was 
unmasked using TBAF and reprotected as the benzyl ether 149. Subsequent hydrolysis 
via reflux in methanol and catalytic p-TsOH yielded the primary alcohol 150 which was 
then oxidized using Jones reagent to acid 151 (Scheme 4-6). Methylation of the 
carboxylic acid using iodomethane and DBU provided the ester functionality at the C-5 
position of 152, which would prove integral in the aldol coupling of the hydroxyisobutyl 
side-chain. At this point in the synthesis a multitude of conditions to achieve aldol 
Scheme 4-6. Functionalization of the C-5 center
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coupling of the ester with isobutyraldehyde were tried. Various benzyl, carbonate and 
carbamate N-protecting groups along with numerous C-4 hydroxyl protecting groups 
were employed to direct the reactivity toward enolization of the C-5 position (Scheme 4-
7). All attempts at aldol coupling of the ester and isobutyraldehyde and/or formaldehyde 
using amide bases were unsuccessful resulting in elimination products or no reaction 
altogether.  
A complete reevaluation of our proposed synthesis followed the unsuccessful 
attempts to achieve the second key-step aldol coupling. The synthetic route to the 
bicyclic γ-lactam had a few shortcomings, namely inconsistencies of the acetonide 
forming step and the amide coupling reaction (not to mention cost of the acid reagent). It 
had also been a consequence of the proposed synthetic route that the natural amino acid 
would ultimately yield the enantiomer of the natural product, thus requiring the use of the 
much less economically feasible (D)-serine as the starting material to obtain the correct 
enantiomer. This synthesis would eventually benefit from the discovery of the 
synthetically superior second generation route to α-diazo-α-(phenylsulfonyl) acetamides 
applied to our earlier methodologies in chapter 3. 
 
4.4 Second Generation Synthesis of the Bicyclic γ-Lactam Intermediate 
 Additional concerns that we had were the lack of significant stereochemical bias 
to affect the aldol-coupling selectively. Originally, the bulky silyl ether was used 
anticipating a need for stereochemical induction. Eventually, this group proved to be 
incompatible with subsequent steps of the synthesis. It had been exchanged for other 
alkyl ethers such as benzyl and methyl although the effectiveness of both toward 
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induction of stereogenic differentiation at the aldol step were ineffective based on the 
distal orientation of the phenyl ring and the size of the methyl group, respectively. We 
settled on using a tert-butyl ether based on its steric presence, resiliency to most 
conditions and its facile introduction and cleavage. The HCl salt of (L)-serine methyl 
ester was subject to the ether forming conditions using liquefied isobutylene and p-TsOH 
in methylene chloride (Scheme 4-8). Initially,this transformation required three days to 
complete. However, our endeavors into the realm of process chemistry provided us with 
optimized conditions for this etherification providing the tert-butyl ether 153. 
Dehydration of the p-toluenesulfonic acid monohydrate shortened the reaction time to 24 
hours and eliminated the need for a closed, pressurized system. Reduction of the ester 
using LAH at 0 °C provided amino alcohol 154 cleanly and in high yield. The acetonide 
formation (155) was achieved using the conditions from the previous methodologies and 
occurred in nearly quantitative yield. N-Acylation using bromoacetyl bromide proceeded 
readily but suffered from mediocre yield and required flash column chromatography for 
Scheme 4-8. Synthesis of the Acetonide Derivative of (L)-Serine
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purification of the bromide (156) (Scheme 4-9). Once again, we were dissatisfied with 
the means by which the bromide was recovered and the yield of the product. We replaced 
the acid bromide with its chloride analog and a much cleaner reaction ensued with 
improved yield. Recovery of chloride 157 consisted of simple recrystallization. 
Displacement of the chloride with benzenesulfinic acid sodium salt occurred readily and 
sulfone 158 was purified by recrystallization. Diazo transfer to the α-position of the 
amide occurred readily using p-ABSA and DBU in acetonitrile providing the α-diazo-α-
(phenylsulfonyl)acetamide C-H insertion precursor 159 which was also purified by 
recrystallization. Application of our standard C-H insertion conditions yielded bicyclic γ-
lactam 160 in high yield regio- and stereoselectively (Scheme 4-10).  
 At this point in the synthetic scheme significant improvements over the first 
generation synthesis were evident by the requirement of less synthetic operations to the γ-
lactam intermediate, product availability from the natural amino acid, incorporation of 
the tert-butyl ether which protects the hydroxyl function and will lend stereochemical 
bias to further transformations. Nowhere were the benefits of our experience in process 
chemistry more apparent than in the techniques used for purification throughout the first 
leg of the synthesis. The first generation synthetic route called for flash column 
purification of six intermediates. Our second generation synthesis of the bicyclic γ-lactam 
Scheme 4-10. γ-Lactam Formton via Rhodium Catalyzed Intramolecular C-H Insertion
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calls for only one flash column purification directly following the insertion step. This 
enabled us to scale-up γ-lactam production without concern for costly and time 
consuming flash column purifications. 
 
4.5 Stereoselective Functionalization of the Bicyclic γ-Lactam 
 With the bicyclic γ-lactam in hand, functionalization of the C-3 and C-5 centers 
became the focus of the next leg of the synthesis. Stereoselective methylation of the C-3 
center occurred readily using NaH and iodomethane in DMF resulting in alkylated 
bicyclic γ-lactam 161 in nearly quavtative yield (Scheme 4-11). We were confident that 
methylation at the C-3 center occurred from the β-face (the convex face) of the γ-lactam 
based on x-ray crystal data obtained from the product of an analogous transformation 
involving the phenylalanine derivative 78. Though, without irrefutable evidence we were 
forced to consider the possibility of α- and β-alkylated products. Following methylation, 
reduction of the phenylsulfone group using 10% Na(Hg) in methanol occurred readily 
resulting in an equal mixture of C-3 epimers 162 and epi-162. This result was not at all 
surprising as we somewhat anticipated a degree of diastereoselection based on the single 
electron transfer mechanism through which this reaction proceeded. We did expect a 
more favorable ratio resulting from the stereochemical and steric bias of the γ-lactam 
Scheme 4-11. Functionalization of the C-3 Center
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itself. An alternate route involving reduction of the phenylsulfone group prior to 
methylation was explored (Scheme 4-12). The α-methylene product (163) of Na(Hg) 
reduction was methylated using LHMDS and iodomethane resulting in the C-3 
methylated γ-lactam with complete diastereoselectivity. Moreover, the original 
methylation-reduction conditions were optimized to yield the desired epimer (162) in a 
diastereoselective manner as well.41 Despite the ambiguity of the C-3 epimers, both were 
carried through the synthesis separately. A one-pot procedure for the hydrolysis of the 
N,O-acetonide and subsequent oxidation of the resultant primary alcohol was devised 
(Scheme 4-13). Essentially, simple Jones oxidation conditions are sufficiently acidic to 
effect hydrolysis of the acetonide moiety and oxidation of the acid (164 and epi-164) 
promptly follows. Methylation of the acid using trimethyl orthoformate in methanol with 
catalytic sulfuric acid resulted in methyl esters 165 and epi-165. Again, numerous 
attempts at forming the quaternary center via aldol coupling of N-protected methyl esters 
were unsuccessful resulting in elimination products and recovered starting materials. In 
Scheme 4-12. Selective α-Methylation of the C-3 Center
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an attempt to activate the C-5 center the amide function was converted to the iminoether 
(166 and epi-166) using Meerwein’s salt in methylene chloride. Addition of iminoether 
166 and epi-166 to LDA in THF at -78 °C resulted in enolization of the ester. 
Isobutyraldehyde was added after 10 minutes followed by saturated ammonium chloride 
solution which resulted in formation of the quaternary C-5 center of 167. Upon 
purification of the products it was revealed that the aldol-coupling of the iminoether 
product derived from the reduction-methylation protocol yielded a single isomer (epi-
167) as a crystalline solid. The methylation-reduction iminoether intermediate (166) 
provided a 2:1 mixture of diastereomers as an oil (Scheme 4-15). X-ray crystal analysis 
of epi-167 revealed that the quaternary center had indeed formed selectively with the 
correct stereochemistry at the C-5 quaternary center and the C-9 center as well. 
Unfortunately, the C-3 center which remained ambiguous until this point was shown to 
Scheme 4-14. Stereoselective Formation of the Quaternary C-5 Center
epi-165 N
O
t-BuO
CO2Me
epi-166
N
t-BuO
O
CO2Me
HO
epi-167
Me3O·BF4
CH2Cl2
isobutyraldehyde
LDA, -78 °C
5
5
9
Scheme 4-15. Formation of the Quaternary C-5 Center of the 3R Intermediate
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be alkylated from the α-face establishing absolute 3S stereochemistry. Epimerization of 
the C-3 methyl center was unsuccessful and this leg of the project was, therefore, 
discontinued.  
 Although, not the results we were hoping for, this data proved invaluable for 
elucidation of the absolute stereochemistry of the C-3 centers of the bicyclic methylated 
compounds 162 and epi-162 and displayed a new and efficient option for stereoselective 
C-3 alkylation of bicyclic γ-lactams. The diastereomeric mixture (167 5R, 9S &167 5S) 
resulting from aldol coupling of the 3R epimer (166) was now the focus and elucidation 
of the absolute stereochemistry was our goal. 
 
4.6 Elucidation of Aldol Stereoselectivity 
 Throughout the course of the aldol coupling two new stereocenters are formed. In 
this case the C-5 and the C-9 stereocenters were those in question. Based on the 
selectivity of the aldol coupling of epi-166 we felt confident that the tert-butyl ether 
“blocking group” was performing its function. A simple test to distinguish which center 
had formed selectively was to oxidize the secondary diastereomeric alcohols (167 5R, 9S 
&167 5S) to ketones (Scheme 4-16). Obviously, if C-9 was the nonselectively-formed 
center, the product of oxidation would be a single isomer. Interestingly, oxidation of the 
mixture using TPAP/NMO conditions resulted in oxidation of one of the diastereomers 
and left the other unreacted as the secondary alcohol, a piece of data which would 
become useful later in the synthesis. Exposure of the mixture to Dess-Martin oxidation 
conditions yielded two different ketone products (168R & S), thus confirming 
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diastereomers at the C-5 center. This result proved that our inclusion of a bulky ether 
substituent failed to induce selectivity for the aldol coupling reaction. Various conditions 
were used to improve the selectivity of the second key-step of the synthesis with no 
success. The best selectivity that could be achieved was a 2:1 ratio of 167 R & S 
diastereomers respectively.  
 An alternate route for formation of the quaternary carbon center which holds 
promise is acylation of iminoether 166 under the same conditions using 
isobutyrylchloride (Scheme 4-17). Ketone 168S is recovered as a 10:1 diastereomeric 
mixture that matches spectral data from that previously generated in the oxidation of the 
167 5R, 9S &167 5S mixture. Reduction of the ketone (168S) at this and the two ensuing 
Scheme 4-16. Oxidation of the C-9 Stereocenters for Structural Elucidation
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Scheme 4-17. Acylation of the Iminoether Occurs with Enhanced Selectivity
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deprotected intermediates resulted in perfect selectivity for 9R secondary alcohol 167 5R, 
9R. This alternate route may eventually prove successful under the selectivity inducing 
reduction conditions or inversion of the selectively formed C-9 center itself. 
  
4.7 Rationalization for Aldol Coupling Stereoselectivity 
 With our first successful aldol transformation from epi-166 in hand, we were 
excited by the high degree of selectivity we experienced. Unfortunately, the same degree 
of selectivity was not obtained for the reaction of 166. Initially, we were confounded by 
the complete lack of stereoselectivity for the latter aldol transformation. The tert-butyl 
ether, which was intended to act as a blocking group, was effective in the case of epi-166 
but rather ineffective as in the case of 166. Assuming that the aldol coupling would 
proceed through a 6-membered transition state, we expected the highly populated face of 
enolate of 166 present with a methyl at C-3 and t-butyl ether at C-4 would only reinforce 
the bias for facial-selectivity during the transformation (Figure 4-1). Therefore, approach 
of the aldehyde would be more likely to occur from the α-face of the enolate as in 166α. 
Our conclusion and explanation for the results we obtained are based on the 
conformation of the enolate substituents in their minimized energy states (Figure 4-2). 
O-
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Figure 4-1. Transition States for Quaternary C-5 Formation
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MM2 calculations using Chem 3D Pro 7.0 show that when the C-3 methyl is on the α-
face of the enolate, the tert-butyl ether can adopt a position which is more facially 
blocking as determined by the dihedral angle of 72° (t-BuO-C-C=C). When the C-3 
methyl is on the β-face of the enolate, a steric repulsion exists between the two 
substituents disallowing the blockage of the β-face by the tert-butyl ether evidenced by 
the dihedral angle of 51°. Obviously, steric consequences of the overpopulated β-face of 
the enolate had a profoundly detrimental effect on this transformation. 
 
4.8 Endgame for the Total Synthesis of clasto-Lactacystin β-Lactone 
 The 2:1 mixture of diastereomers (167 5R, 9S &167 5S) was carried forward 
through the deprotection stage of the synthesis using anhydrous TFA for cleavage of the 
tert-butyl protecting group yielding a mixture of diols (169 5R, 9S/169 5S). Exposure of 
the diols to 1% HCl in methanol resulted in the known amide 170 5R, 9S as a mixture of 
N
MeO
t-BuO LiO
OMe
N
MeO
t-BuO LiO
OMe
Dihedral Angle( t-BuO-C-C=C): 72° Dihedral Angle( t-BuO-C-C=C): 51°
Figure 4-2. Rationalization of Aldol Coupling Stereoselectivity
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diastereomers with 170 5S. The major component of the resulting mixture was identical 
to the 1H NMR spectral data reported by Adam’s and Smith for the amide 169 5R, 9S. 
This data was useful by confirming that aldol product 167 5R, 9S was formed with a 
favorable yet mediocre ratio. Combined with the results of oxidation of the aldol 
diastereomers, we were able to distinguish the stereochemical configuration of the 
product of the acylation methodology and declare it a viable alternative to the aldol 
coupling.  
 Completion of the synthesis of the β-lactone 2 was accomplished using Adams’ 
method of basic hydrolysis of the methyl ester to the dihydroxy acid followed by 
activation to the mixed anhydride which spontaneously lactonized resulting in 2 as a 
single isomer. The corresponding diastereomer was most likely hydrolyzed but was not 
fit for lactonization based on the trans-arrangement of the hydroxyl and carboxylic acid 
substituents and subsequently lost during work-up of 2. The synthetic β-lactone 2 was 
identical spectroscopically to reported data and an x-ray crystal analysis confirmed the 
absolute stereochemistry of the final product. The total synthesis of 2 was accomplished 
in 17 steps with a 10% overall yield. 
 Made obvious by the elegant and elaborate syntheses highlighted above, 
lactacystin (1) and its analogs have been intensely pursued by some of the most 
Scheme 4-18. Endgame for the Total Synthesis of clasto-Lactacystin β-Lactone
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prestigious and successful synthetic groups in recent years. Moreover, it is a perfect 
example of the significant role natural product synthesis plays in the scientific 
community. Seldom do we experience the discovery of a natural target that possesses 
such novel biological activity and specificity. Because of scant supply, the only practical 
means of obtaining material for further research is through total synthesis. 
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Chapter Five 
Experimental Data 
 
 
 All experiments were carried out under nitrogen atmosphere using oven dried 
glassware (or flame dried when necessary). All chemicals were purchased from Aldrich 
Chemical Co. and/or Acros Organics and used without further purification unless 
otherwise noted. Methylene chloride was distilled over calcium hydride. THF and diethyl 
ether were distilled over sodium metal. Proton nuclear magnetic resonance (250 MHz) 
and 13C (63 MHz) spectra were recorded at room temperature in CDCl3 unless otherwise 
noted. All chemical shifts are reported as δ relative to CHCl3 (δH 7.26 ppm) and CDCl3 
(δC 77.0 ppm) as internal standards, respectively, using a Bruker DPX 250 spectrometer. 
Infrared spectra were recorded using a Nicolet Magna FTIR 550 spectrometer and are 
reported in reciprocal centimeters (cm-1). Elemental analysis was preformed by Atlantic 
Microlab, Inc., Norcross, GA. Thin layer chromatography (TLC) was preformed on EMD 
precoated silica plates with silica gel 60 Å, 250 µm thickness. Visualization of TLC was 
accomplished using a UV lamp (254 nm), iodine or charring solutions (ninhydrin and 
PMA). Flash column chromatography was performed on Whatman Purasil 60 Å (230-400 
mesh) silica gel. 
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Preparation of Phenylthioacetamide 75 from (L)-Phenylalanine 
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 Thionyl chloride (3.65 mL, 50 mmol) was added drop wise to a solution of (L)-
phenylalanine (7.6 g, 46 mmol) in methanol (60 mL) at 0 °C, and the mixture was heated 
under reflux 1 h. The solvent was evaporated to give (L)-phenylalanine methyl ester, 
hydrochloride as white solid. To a solution of (L)-phenylalanine methyl ester 
hydrochloride (46 mmol), phenylthioacetic acid (8.5 g, 51 mmol) and imidazole (4.1 g, 
60 mmol) in DMF ( 50 mL, C = 1.0 M), was slowly added N,N’-diisopropylcarbodiimide 
(8 mL, 51 mmol) at 0 °C. The mixture was stirred briefly at 0 °C and then at r.t. for 12 h. 
After filtration of the precipitate, the filtrate was diluted with EtOAc and the organic 
layer was washed twice with water and dried over Na2SO4. After evaporation of solvent, 
the resulting residue was recrystallized with hexanes-EtOAc to afford desired product 75 
(15 g, 97%) as white solid: 1H NMR (250 MHz, CDCl3) δ 7.31-7.18 (m, 10 H), 6.95 (m, 
1 H), 4.85 (m, 1 H), 3.68 (s, 3 H), 3.61 (s, 2 H), 3.06 (d, 2 H, J = 5.9 Hz), 13C NMR (62.5 
MHz, CDCl3) δ 171.4, 167.7, 135.5, 134.5, 129.2, 129.1, 128.6, 128.3, 127.1, 126.7, 
53.3, 52.3, 37.7, 37.4; IR (thin film, cm-1) 1744, 1676, 1512, 1265. 
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Preparation of Alcohol 75A 
 
NH
CO2Me
PhS
O
Ph
75
NH
PhS
O
Ph
NaBH4/LiCl
OHTHF/MeOH
75A  
 
 To a solution of phenylthioacetylmide methyl ester 75 (10 g, 30 mmol) in THF-
MeOH (150 ml, C = 0.2 M, 1:1 vol. ratio), were slowly added NaBH4 (3.4 g, 90 mmol) 
followed by LiCl (3.7 g, 90 mmol) at 0 °C. The resulting mixture was stirred for 1 h at 
r.t., and the solvent was evaporated. The residue was partitioned with EtOAc and brine, 
and the organic layer was dried over Na2SO4 and concentrated. The resulting residue was 
recrystallized with hexanes-EtOAc to afford primary alcohol 75A (8.6 g, 95%) as white 
solid: 1H NMR (250 MHz, CDCl3) δ 7.31-7.10 (m, 10 H), 7.03 (br d, 1 H), 4.14 (m, 1 H), 
3.66 and 3.56 (ABq, 2 H, J = 17.1 Hz), 3.53 (m, 2 H), 2.79 (m, 2 H), 2.14 (t, 1 H, J = 5.7 
Hz); 13C NMR (62.5 MHz, CDCl3) δ 168.3, 137.1, 135, 129.3, 129.1, 128.1, 126.7, 64.1, 
53.1, 37.5, 36.8; IR (thin film, cm-1) 3290, 1661, 1540, 1265.  
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Preparation of Acetonide 76  
 
NH
PhS
O
Ph
OH
2,2-DMP, p-TsOH
PhCH3, reflux
Dean-Starke
N
O
PhS
O
Ph
7677A  
 
 Primary alcohol 77A (6 g, 20 mmol) is added to a mixture of 2,2-
dimethoxypropane (4.8 mL, 40 mmol), and catalytic p-toluenesulfonic acid in toluene (70 
ml, C = 0.3 M). The solution is heated under reflux for 1 hr using a Dean-Starke 
apparatus for the removal of water. The reaction mixture was poured into saturated 
NaHCO3 and extracted with EtOAc. The combined organic layer was washed with brine, 
then dried over Na2SO4, filtered and concentrated to give crude product as an oil, which 
was chromatographed to afford acetonide 76 (4.8 g, 70 %): 1H NMR (250 MHz, CDCl3) 
δ 7.52-7.11 (m, 10 H), 4.04 (m, 1 H), 3.79 (m, 2 H), 3.48 and 3.40 (ABq, 2 H, J = 13.7 
Hz), 2.89 (m, 2 H), 2.05 (s, 3 H), 1.47 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 165.3, 
137.2, 134.7, 131.1, 129.2, 129.0, 127.3, 127.1, 95.8, 66.9, 59.4, 40.7, 38.9, 26.9, 22.7; 
IR (thin film, cm-1) 1652, 1496, 1265. 
 66
Preparation of Phenylsulfone 77 
 
N
O
PhS
O
Ph
76
m-CPBA
CH2Cl2, 0 °C
N
O
PhSO2
O
Ph
76A  
 
 To a solution of phenylthioacetamide 76 (3.7 g, 10.8 mmol) in dry CH2Cl2 (54 
mL, C = 0.2 M) m-CPBA (6.7 g, 27 mmol) was slowly added and stirred for 1 hr at 0 °C. 
The reaction mixture was poured into 1 N NaOH, and extracted with CH2Cl2. The 
organic layer was washed with brine, dried over Na2SO4, filtered and concentrated 
yielding pure phenylsulofone 76A: 1H NMR (250 MHz, CDCl3) δ 7.84-7.50 (5 m, 5 H), 
7.36-7.17 (m, 5 H), 4.39 (m, 1 H), 4.01 (dd, 1H, J = 5.0, 8.9 Hz), 3.87 (d, 1H, J = 8.9 
Hz), 3.81 and 3.41 (ABq, 2 H, J = 13.8 Hz), 2.93 (m, 2 H), 1.71 (s, 3H), 1.51 (s, 3 H); 13C 
NMR (62.5 MHz, CDCl3) δ 158.3, 138.7, 137.0, 134.2, 129.4, 129.2, 129.0, 128.4, 127.3, 
96.1, 67.5, 61.7, 60.0, 40.8, 26.6, 22.5; IR (thin film, cm-1) 1738, 1373, 1245, 1046. 
 
General Preparation of α-Diazo-α-(phenylsulfonyl)acetamides. 
 To a mixture of a α-(phenylsulfonyl)acetamide (5.0 mmol) and p-
acetamidobenzenesulfonyl azide (1.3 g, 5.5 mmol) in dry CH3CN (25 mL, C = 0.2 M), 
was slowly added DBU (1.64 mL, 11 mmol) at 0 °C. The resulting mixture was stirred 
for 1 hr at 0 °C, and the solvent was evaporated. The residue was diluted with Et2O, and 
the mixture was washed successively with 1 N NaOH, water, and brine. The yellow 
organic layer was dried over Na2SO4, filtered, and concentrated. The residue was 
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chromatographed to give α-diazo-α-(phenylsulfonyl)acetamide.  
 
N
O
PhSO2
O
Ph
77
N2
 
 
 77: 1H NMR (250 MHz, CDCl3) δ 7.96-7.51 (m, 5 H), 7.35-7.17 (m, 5 H), 4.39 
(m, 1 H), 3.85 (d, 2 H, J = 3.6 Hz), 3.08 (dd, 1 H, J = 5.3, 13.5 Hz), 2.81 (dd, 1 H, J = 
9.3, 13.5 Hz), 1.69 (s, 3 H), 1.34 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 153.9, 141.9, 
136.5, 133.9, 129.4, 129.2, 128.8, 127.5, 127.1, 96.7, 74.8, 67.1, 58.7, 40.0, 26.9, 23.4; 
IR (thin film, cm-1) 2086, 1734, 1641, 1371, 1265, 1047. 
 
N
O
PhSO2
O
84
N2
 
 
 84: 1H NMR (250 MHz, CDCl3) δ 8.03-7.53 (m, 5 H), 4.01 (dd, 1 H, J = 5.0, 9.0 
Hz), 3.82 (dd, 1 H, J = 2.5, 9.0 Hz), 3.79 - 3.73 (m, 1 H), 1.75-1.65 (m, 2 H) 1.64 (s, 3 
H), 1.42 (s, 3 H), 0.91 (t, 3 H, J = 7.4 Hz); 13C NMR (62.5 MHz, CDCl3) δ 153.8, 142.0, 
133.8, 129.1, 127.8, 96.6, 74.3, 67.3, 58.6, 26.9, 26.2, 23.6, 10.1; IR (thin film, cm-1) 
1696, 1419, 1367, 1304, 1141, 1080, 1026. 
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N
O
PhSO2
O
86
N2
 
 
 86: 1H NMR (250 MHz, CDCl3) δ 8.02-7.53 (m, 5 H), 4.0 (m, 1 H), 3.83 (m, 2 
H), 1.64 (m, 2 H) 1.61 (s, 3 H), 1.41 (s, 3 H), 1.31 (m, 2 H), 0.96 (t, 3 H, J = 7.2 Hz); 13C 
NMR (62.5 MHz, CDCl3) δ 153.6, 141.9, 133.7, 129.0, 127.7, 96.4, 74.1, 67.6, 57.2, 
36.1, 26.2, 23.5, 19.1, 13.8; IR (thin film, cm-1) 2089, 1638, 1388, 1153, 1085. 
 
N
O
PhSO2
O
88
N2
 
 
 88: 1H NMR (360 MHz, CDCl3) δ 8.01-7.55 (m, 5 H), 4.06 - 3.95 (m, 2 H), 3.81 
(dd, 1 H, J = 2.7, 6.1 Hz) 1.63 (s, 3 H), 1.41 (s, 3 H), 0.97 (d, 3 H, J = 3.5 Hz), 0.96 (d, 3 
H, J = 3.8 Hz); 13C NMR (62.5 MHz, CDCl3) δ 153.5, 141.9, 133.8, 129.0, 127.6, 96.1, 
73.6, 67.8, 56.2, 43.1, 26.3, 25.5, 23.6, 21.3; IR (thin film, cm-1) 2092, 1645, 1388, 1266, 
1155, 1084. 
 
 69
N
O
PhSO2
O
90
N2
Ph
 
 
 90: 1H NMR (250 MHz, CDCl3) δ 8.02-7.52 (m, 5 H), 7.36 - 7.18 (m, 5 H), 4.02 
(dd, 1 H, J = 5.7, 8.7 Hz) 3.88 (d, 1 H, J = 8.7 Hz), 3.82 (m, 1 H), 2.74-2.50 (m, 2 H), 
2.02 (m, 2 H), 1.63 (s, 3 H), 1.41 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 153.7, 142.0, 
140.0, 133.8, 129.1, 128.8, 128.3, 127.8, 126.5, 96.5, 74.0, 67.5, 56.8, 35.8, 32.3, 26.4, 
23.7; IR (thin film, cm-1) 2102, 1617, 1374, 1308, 1142, 1083. 
 
N
O
PhSO2
O
92
N2
MeO2C
 
 
 92: 1H NMR (250 MHz, CDCl3) δ 8.0-7.54 (m, 5 H), 4.08-3.97 (m, 1 H), 3.81 (d, 
1 H, J = 9.0 Hz), 3.73 (s, 3 H), 2.36 (m, 2 H), 1.99 (m, 2 H), 1.64 (s, 3 H), 1.39 (s, 3 H); 
13C NMR (62.5 MHz, CDCl3) δ 172.4, 153.9, 141.8, 133.8, 129.1, 127.6, 96.4, 74.3, 67.3, 
56.5, 51.9, 30.0, 29.0, 26.6, 23.4; IR (thin film, cm-1) 2096, 1730, 1630, 1391, 1317, 
1147, 1080. 
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N
O
PhSO2
O
94
N2
4-(MeO)Ph
 
 
 94: 1H NMR (250 MHz, CDCl3) δ 7.98-7.57 (m, 5 H), 7.13 (d, 2 H, J = 8.5 Hz), 
6.88 (d, 1 H, J = 8.5 Hz), 4.27 (m, 1 H), 3.87 (d, 2 H, J = 3.2 Hz), 3.8 (s, 3 H), 3.03 (dd, 1 
H,  J = 5.0, 13.0 Hz), 2.79 (dd, 1 H, J = 8.9, 13.0 Hz), 1.69 (s, 3 H), 1.36 (s, 3 H); 13C 
NMR (62.5 MHz, CDCl3) δ 158.6, 154, 141.8, 133.9, 130.5, 129.3, 128.4, 127.5, 114.3, 
96.7, 74.8, 67.2, 59.1, 55.2, 39.3, 26.9, 23.4; IR (thin film, cm-1) 2087, 1623, 1512,  1363, 
1244, 1150, 1083. 
 
N
O
PhSO2
O
96
N2
 
 
 96: 1H NMR (250 MHz, CDCl3) δ 8.0-7.51 (m, 5 H), 4.09-3.94 (m, 2 H), 3.68 
(dd, 1 H, J = 3.0, 8.5 Hz), 1.60 (s, 3 H), 1.40 (s, 3 H), 1.26 (d, 3 H, J = 6.1 Hz); 13C NMR 
(62.5 MHz, CDCl3) δ 153.7, 142.0, 133.8, 129.1, 127.7, 96.7, 74.2, 69.9, 52.8, 26.2, 23.8, 
20.1; IR (thin film, cm-1) 2097, 1641, 1257, 1156. 
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N
O
PhSO2
O
98
N2
 
 
 98: 1H NMR (250 MHz, CDCl3) δ 8.0-7.51 (m, 5 H), 3.95-3.79 (m, 3 H), 2.10 (m, 
1 H), 1.64 (s, 3 H), 1.40 (s, 3 H), 0.95 (d, 3 H, J = 7.0 Hz), 0.90 (d, 3 H, J = 6.7 Hz); 13C 
NMR (62.5 MHz, CDCl3) δ 154.5, 142.0, 133.8, 129.2, 127.6, 96.6, 74.8, 64.9, 62.3, 
30.0, 25.9, 23.6, 19.1, 16.8; IR (thin film, cm-1) 2097, 1641, 1268, 1048. 
 
N
O
PhSO2
O
100
N2
 
 
 100: 1H NMR (250 MHz, CDCl3) δ 8.01-7.26 (m, 5 H), 3.98-3.82 (m, 3 H), 1.85 
(m, 1 H), 1.61 (s, 3 H), 1.41 (s, 3 H), 1.4 - 1.0 (m, 2 H), 0.95 (t, 2 H, J = 7.2 Hz), 0.85 (d, 
3 H, J = 6.8 Hz); 13C NMR (62.5 MHz, CDCl3) δ 154.4, 141.9, 133.8, 129.1, 127.6, 96.6, 
74.5, 64.5, 61.0, 36.3, 26.2, 25.3, 23.9, 13.3, 12.1; IR (thin film, cm-1) 2097, 1641, 1257, 
1156. 
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O
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103
N2
 
 
 103: 1H NMR (250 MHz, CDCl3) δ 8.0-7.53 (m, 5 H), 3.98 (m, 3 H), 3.62 (m, 2 
H), 1.58 (s, 3 H), 1.41 (s, 3 H), 0.86 (s, 9 H), 0.059 (s, 6 H); 13C NMR (62.5 MHz, 
CDCl3) δ 154.1, 142.1, 133.7, 129.0, 127.8, 96.8, 74.6, 65.9, 62.7, 58.2, 26.5, 25.7, 23.5, 
18.2, -5.58, IR (thin film, cm-1) 2092, 1634, 1448, 1378, 1261, 1155, 1087. 
 
N
O
PhSO2
O
OTBS
105
N2
 
 
 105: 1H NMR (250 MHz, CDCl3) δ 8.0-7.53 (m, 5 H), 4.24 (dq, 1 H, J = 6.3, 6.3 
Hz), 3.92 (dd, 1 H, J = 5.5, 10.0 Hz), 3.73 (dd, 1 H, J = 2.5, 10.0 Hz), 3.55 (m, 1 H), 1.56 
(s, 3 H), 1.42 (s, 3 H), 1.36 (d, 3 H, J = 6.1 Hz), 0.89 (s, 9 H), 0.092 (s, 3 H), 0.082 (s, 3 
H); 13C NMR (62.5 MHz, CDCl3) δ 154.9, 141.9, 133.8, 129.1, 127.5, 96.4, 75.5, 73.7, 
64.6, 61.0, 60.2, 25.7, 25.6, 24.5, 20.9, 19.1, 18.2, 14.1, -5.68, -5.79; IR (thin film, cm-1) 
2090, 1646, 1344, 1253, 1154, 1086. 
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General Procedure for Rhodium Catalyzed Intramolecular C-H Insertion 
 To a solution of an α-diazo-α-(phenylsulfonyl)acetamide (1 mmol) in dry CH2Cl2 
(20 mL), was added Rh2(OAc)4 (11 mg, 2.5 mol%). The mixture was refluxed for 12 h 
under N2, cooled to r.t., and concentrated. The residue was chromatographed to give pure 
γ-lactam. 
 
N
O
O
Ph
PhSO2
H
78  
 
 78: 1H NMR (250 MHz, CDCl3) δ 7.93-7.49 (m, 5 H), 7.35-7.23 (m, 5 H), 4.50 
(d, 1 H, J = 9.1 Hz), 4.14-4.05. (m, 2 H), 3.88 (dd, 1 H, J = 6.2, 9.1 Hz), 3.68 (dd, 1 H, J 
= 7.9, 8.0 Hz), 1.65 (s, 3 H), 1.45 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ; IR (thin 
film, cm-1) 1734, 1373, 1266, 1246, 1046. 
 
N
O
O
PhSO2
H
85  
 
 85: 1H NMR (250 MHz, CDCl3) δ 8.01-7.54 (5 H, m) 4.12 (dd, 1 H, J = 5.5, 8.5 
Hz), 4.00 (d, 1 H, J = 9.9 Hz), 3.73 (m, 1 H), 3.48 (dd, 1 H, J = 8.5, 9.0 Hz), 2.81 (m, 1 
H), 1.51 (s, 3 H), 1.42 (d, 3 H, J = 6.7 Hz), 1.38 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 
161.7, 137.8, 134.1, 129.8, 128.8, 92.4, 76.2, 68.8, 64.9, 34.1, 26.4, 23.5, 18.7; IR (thin 
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film, cm-1) 1696, 1419, 1367, 1304, 1142, 1080, 1023. 
 
N
O
O
Et
PhSO2
H
87  
 
 87: 1H NMR (250 MHz, CDCl3) δ 8.01-7.54 (5 H, m), 4.10 (dd, 1 H, J = 4.1, 8.6 
Hz), 4.05 (d, 1 H, J = 9.6 Hz), 3.77 (m, 1 H), 3.51 (dd, 1 H, J = 8.6, 9.0 Hz), 2.68 (m, 1 
H), 2.2 (m, 1 H), 1.54 (s, 3 H), 1.40 (s, 3 H), 0.97 (t, 3 H, J = 7.4 Hz); 13C NMR (62.5 
MHz, CDCl3) δ 161.6, 137.7, 134.0, 129.7, 128.7, 91.9, 74.7, 69.4, 63.6, 40.2, 26.4, 26.3, 
23.3, 11.6; IR (thin film, cm-1) 1698, 1416, 1306, 1142, 1082, 1028. 
 
N
O
O
PhSO2
H
89  
 
 89: 1H NMR (250 MHz, CDCl3) δ 8.03-7.58 (5 H, m), 4.16 (d, 1 H, J = 8.2 Hz), 
4.07 (dd, 1 H, J = 5.5, 7.9 Hz), 3.87 (m, 1 H), 3.59 (dd, 1 H, J = 7.9, 9.3 Hz) 2.79 (1H, 
m), 2.22 (m, 1 H), 1.62 (s, 3H), 1.45 (s, 3H), 1.05 (d, 3 H, J = 6.7 Hz), 1.04 (d, 3 H, J = 
6.9 Hz); 13C NMR (62.5 MHz, CDCl3) δ 162.4, 137.9, 134.1, 129.7, 128.8, 92.4, 72.7, 
69.6, 59.9, 42.3, 29.1, 26.9, 23.4, 20.6, 17.5 ; IR (thin film, cm-1) 1706, 1407, 1309, 1266, 
1150, 1085. 
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N
O
O
Bn
PhSO2
H
91  
 
 91: 1H NMR (250 MHz, CDCl3) δ 8.08-7.50 (5 H, m), 7.37-7.21 (m, 5 H), 4.22 
(d, 1 H, J = 10.2 Hz), 3.78 (m, 1 H), 3.55 (dd, 1 H, J = 3.9, 13.3 Hz) 3.21-3.01 (m, 2 H), 
2.70 (dd, 1 H, J = 11.6, 13.0 Hz), 1.45 (s, 3H), 1.35 (s, 3 H); 13C NMR (62.5 MHz, 
CDCl3) δ 161.2, 137.8, 134.2, 129.8, 129, 128.9, 128.7, 127.2, 91.9, 74.3, 68.9, 63.1, 
41.8, 38.9, 26.3, 23.4; IR (thin film, cm-1) 1694, 1316, 1308, 1145, 1083, 1025.  
 
N
O
O
PhSO2
H
MeO2C
93  
 
 93: 1H NMR (250 MHz, CDCl3) δ 8.03-7.26 (5 H, m), 4.23-4.16 (m, 2 H), 3.81 
(m, 1 H), 3.72 (s, 3 H), 3.58 (dd, 1 H, J = 9.0, 9.1 Hz), 3.24 (dd, 1 H, J = 3.3, 17.2 Hz), 
3.09 (m, 1 H), 2.67 (dd, 1 H, J = 10.5, 17.2 Hz), 1.49 (s, 3H), 1.39 (s, 3H); 13C NMR 
(62.5 MHz, CDCl3) δ 171.6, 160.9, 137.1, 134.3, 129.9, 128.8, 92.1, 73.5, 69.9, 63.8, 
52.0, 36.7, 35.3, 26.4, 23.3; IR (thin film, cm-1) 1734, 1705, 1281, 1143, 1080, 1036. 
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H
4-(MeO)Ph
95  
 
 95: 1H NMR (250 MHz, CDCl3) δ 7.95-7.50 (m, 5 H, 7.19 (d, 2 H, J = 8.6 Hz), 
6.89 (d, 1 H, J = 8.6 Hz), 4.46 (d, 1 H, J = 8.6 Hz), 4.16-4.07 (m, 2 H), 3.86 (m, 1 H), 
3.81 (s, 3 H), 3.70 (m, 1 H), 1.66 (s, 3 H), 1.46 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 
161.7, 159.2, 137.7, 134.1, 130.7, 129.7, 128.8, 128.5, 114.6, 92.9, 69.0, 65.9, 55.3, 42.8, 
26.7, 23.5; IR (thin film, cm-1) 1711, 1365, 1217. 
 
N
O
O
PhSO2
H
97  
 
 97: 1H NMR (250 MHz, CDCl3) δ 8.0-7.34 (m, 5 H), 3.42-4.02 (m, 3 H), 3.39 (m, 
1 H), 2.89-2.17 (m, 2 H), 1.56 and 1.53 (s, 3H), 1.38 (s, 3 H); IR (thin film, cm-1) 1700, 
1405, 1310, 1265, 1150, 1085, 1039. 
 
N
O
O
PhSO2
H
99  
 
 99: 1H NMR (250 MHz, CDCl3) δ 8.06-7.49 (m, 5 H), 4.49 and 3.78 (m, 3 H), 
4.07 and 3.54 (s, 1 H), 1.60 and 1.59 (s, 3 H), 1.50 (s, 3 H), 1.43 and 1.42 (s, 3 H), 1.32 
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and 1.11 (s, 3 H); IR (thin film, cm-1) 1701, 1448, 1393, 1147, 1058, 1214, 1085, 1036. 
 
N
O
O
PhSO2
H
Et
Me
101  
 
 101: 1H NMR (250 MHz, CDCl3) δ 8.10-7.53 (m, 5 H), 4.56 and 3.80 (m, 3 H), 
4.12 and 3.61 (s, 1 H), 2.30 (m, 1 H), 1.63 and 1.52 (s, 3 H), 1.47 (s, 3 H), 1.37 and 1.11 
(s, 3 H), 0.94 and 0.91 (t, 3 H, J = 7.5 Hz); IR (thin film, cm-1) 1706, 1422, 1369, 1265, 
1150, 1084. 
 
N
O
O
TBSO
PhSO2
H
104  
 
 104: 1H NMR (360 MHz, CDCl3) δ 8.01-7.55 (m, 5 H), 4.83 (dd, 1 H, J = 4.8, 6.7 
Hz), 4.26 (d, 1 H J = 6.8 Hz), 4.17 (dd, 1 H, J = 5.8, 8.2 Hz), 3.97 (ddd, 1 H, J = 4.8, 5.8, 
8.4 Hz), 3.60 (dd, 1 H, J = 8.4, 8.4 Hz), 1.57 (s, 3 H), 1.41 (s, 3 H), 0.91 (s, 9 H), 0.24 (s, 
3 H), 0.17 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 160.7, 138.1, 134.1, 129.6, 128.8, 
92.7, 77.8, 69.3, 67.6, 66.8, 26.6, 25.6, 23.4, 17.9, -4.85, -5.15; IR (thin film, cm-1) 1713, 
1447, 1371, 1265, 1153, 1082. 
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O
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 106: 1H NMR (360 MHz, CDCl3) δ 7.97-7.54 (m, 5 H), 4.85 (dd, 1 H, J = 3.5, 4.8 
Hz), 4.12 (d, 1 H J = 4.8 Hz), 3.82 (m, 1 H), 3.51 (dd, 1 H, J = 3.5, 9.3 Hz), 1.59 (s, 3 H), 
1.43 (s, 3 H), 1.35 (d, 3 H, J = 6.0 Hz), 0.91 (s, 9 H), 0.27 (s, 3 H), 0.23 (s, 3 H); 13C 
NMR (62.5 MHz, CDCl3) δ 161.5, 137.9, 134.2, 129.6, 129.2, 128.8, 92.5, 79.2, 74.4, 
73.8, 67.0, 27.5, 25.6, 23.6, 17.9, 16.8, -4.51, -5.17 ; IR (thin film, cm-1) 1718, 1310, 
1250, 1151, 1083. 
 
Preparation of γ-lactam 105 
 
N
O
O
PhSO2
H
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O
H
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102
Na(Hg)
NaH2PO4
MeOH
 
 
 To a solution of γ-lactam 101 (62 mg, 0.18 mmol) and anhydrous disodium 
hydrogen phosphate (104 mg, 0.72 mmol) in 2 mL of methanol cooled to the 0 °C was 
added pulverized 10% sodium amalgam (168 mg). The mixture was stirred for 30 min., 
poured into water and extracted with ether. The organic layer was dried over Na2SO4, 
filtered and concentrated. The residue was chromatographed to give the reduced γ-lactam 
in 83% yield as a single isomer: 1H NMR (250 MHz, CDCl3) δ 3.94 (dd, 1 H, J = 6.2, 8.7 
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Hz), 3.85 (dd, 1 H, J = 6.2, 8.5 Hz), 3.68 (dd, 1 H, J =  8.5 , 8.7 Hz), 2.87 and 1.94 (ABq, 
2 H, J = 16 Hz) 1.62 (s, 3 H), 1.44 (s, 3 H), 0.99 (s, 3 H), 0.84 (t, 3 H, J = 7.4 Hz); 13C 
NMR (62.5 MHz, CDCl3) δ 170.0, 90.3, 68.6, 63.8, 51.4, 40.6, 32.8, 26.0, 23.4, 19.0, 9.5; 
IR (thin film, cm-1) 1700. 
 
General Preparation of α-Amino Acid Derived N,O-Acetonides 
 To a suspension of LAH (3.8 g, 100 mmol) and 250 mL of anhydrous THF (0.2 
M) cooled to 0 °C was slowly added 50 mmol of α-amino acid. The entire suspension 
was then refluxed under N2 atmosphere for 8 hrs. The reaction mixture was cooled to 0 
°C and, while stirring, 3.8 mL of water was added via dropping funnel. It was followed 
by 3.8 mL of 20% NaOH and 7.6 mL of water. The entire solution was then stirred for an 
additional half hour and filtered through a sintered glass funnel with a celite pad. The 
filter cake was rinsed with a portion of anhydrous THF and the filtrate was then 
evaporated yielding the crude amino alcohol. The crude product was then combined with 
250 mL of a 1:1 mixture of acetone and 1,2-DCE and 10 grams of anhydrous Na2SO4 and 
refluxed under N2 atmosphere for 1 hr. The solution was then cooled to r.t. and filtered 
through a sintered glass funnel with a pad of celite. The filter cake was rinsed with a 
portion of acetone and the filtrate was evaporated yielding the crude acetonide. 
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110: 1H NMR (250 MHz, CDCl3) δ 7.33-7.19 (m, 5 H), 3.87 (dd, 1 H, J = 7.1, 7.4 
Hz), 3.69 (m, 1 H), 3.39 (dd, 1 H, J = 7.7, 7.8 Hz), 3.00 (dd, 1 H, J = 5.8, 13.6 Hz), 2.72 
(dd, 1 H, J = 7.8, 13.6 Hz) 1.44 (s, 3 H), 1.31 (s, 3H); 13C NMR (62.5 MHz, CDCl3) δ 
137.7, 128.3,128.1, 126.0, 94.6, 69.7, 58.6, 39.0, 27.3, 26.1. 
 
General Preparation of α-Amino Acid Derived N,N’-Acetonides 
 Thionyl chloride (3.65 mL, 50 mmol) was added drop wise to a solution of (L)-
phenylalanine (7.6 g, 46 mmol) in methanol (60 mL) at 0 °C, and the mixture was heated 
under reflux 1 h. The solvent was evaporated to give (L)-phenylalanine methyl ester 
hydrochloride as white solid. The solid was then redissolved in MeOH and methylamine 
was added and stirred for 4 hrs. The solvent was evaporated and the residue was 
dissolved in EtOAc and neutralized with 1 N HCl. The organic solution was dried and 
concentrated yielding crude aminoamide. The crude product was then combined with 250 
mL of a 1:1 mixture of acetone and 1,2-DCE and 10 grams of anhydrous Na2SO4 and 
refluxed under N2 atmosphere for 1 hr. The solution was then cooled to r.t. and filtered 
through a sintered glass funnel with a pad of celite. The filter cake was rinsed with a 
portion of acetone and the filtrate was evaporated yielding the crude acetonide. 
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 131: 1H NMR (250 MHz, CDCl3) δ 7.25-7.00 (m, 5 H), 3.64 (dd, 1 H, J = 4.5, 7.6 
Hz), 2.98, (dd, 2 H, J = 4.4, 14.1 Hz), 2.57 (s, 3 H), 1.09 (s, 3 H), 0.99 (s, 3 H); 13C NMR 
(62.5 MHz, CDCl3) 172.7, 136.6, 128.9, 127.9, 126.1, 75.0, 58.6, 36.6, 26.5, 24.5. 
 
General Preparation of α-Diazo-α-(ethoxycarbonyl)acetamides 
 To a solution of crude acetonide (10 mmol) in anhydrous THF (50 mL) and TEA 
(0.153 mL, 11 mmol) at 0 °C was added methyl-3-chloro-3-oxopropionate (0.118 mL, 11 
mmol) and stirred under N2 atmosphere for 1 hr. The reaction mixture was evaporated 
and the residue was diluted with EtOAc and washed with water, dried and concentrated. 
The crude product was then diluted with MeCN (50 mL) and p-ABSA (360 mg, 15 
mmol) added. The solution was cooled to 0 °C, DBU was added drop wise and the 
mixture was stirred for 12 hrs. The reaction mixture was then evaporated, the residue 
dissolved in equal parts EtOAc and water and the organic phase was then washed with 
water twice, dried and concentrated. The red-brown residue was purified by flash column 
and the pale yellow product was recovered as an oil. 
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 111: 1H NMR (250 MHz, CDCl3) δ 7.12-6.92 (m, 5 H), 3.99 (q, 2 H, J = 7.2 Hz), 
3.78 (m, 1 H), 3.77 (dd, 1 H, 5.0, 8.5 Hz), 3.62 (d, 1 H, J = 8.5 Hz), 2.78 (dd, 1 H, J = 
7.9, 12.9 Hz), 2.57 (dd, 1 H, J = 6.8, 13.1 Hz), 1.78 (s, 3 H), 1.31 (s, 3 H), 1.06 (t, 3 H, J 
= 7.0 Hz); 13C NMR (62.5 MHz, CDCl3) 161.8, 157.2, 137.5, 129.1, 128.4, 126.7, 96.2, 
68.3, 67.8, 60.8, 58.6, 40.7, 27.4, 23.0, 14.2. 
 
N
O
MeO
O O
N2
124  
 
 124: 1H NMR (250 MHz, CDCl3) δ 4.15 (ddd, 1 H, J = 2.3, 5.8, 13.9 Hz), 3.88 
(dd, 1 H, J = 5.8, 8.6 Hz), 3.65 (s, 3 H), 3.67 - 3.61 (m, 1 H), 1.53 (s, 3 H), 1.43 (m, 2 H), 
1.36 (s, 3 H), 1.12 (m, 2 H), 0.75 (t, 3 H, J = 7.3 Hz); 13C NMR (62.5 MHz, CDCl3) 
162.5, 156.8, 95.9, 67.7, 67.5, 57.0, 52.1, 36.3, 26.7, 23.3, 19.2, 13.6. 
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 133: 1H NMR (250 MHz, CDCl3) δ 7.26-6.94 (m, 5 H), 4.97 (t, 1 H, J = 4.5 Hz), 
3.66 (s, 3 H), 3.04 (d, 2 H, J = 4.6 Hz), 2.63 (s, 3 H), 1.43 (s, 3 H), 0.87 (s, 3 H); 13C 
NMR (62.5 MHz, CDCl3) 167.0, 161.2, 158.1, 135.6, 129.2, 128.1, 126.7, 80.0, 68.4, 
59.6, 51.8, 37.3, 23.8, 23.0, 22.7. 
 
General Preparation of α-Diazo-α-(acetyl)acetamides 
 To a solution of acetonide (10 mmol) in anhydrous THF (50 mL) at 0 °C was 
added diketene (0.848 mL, 11 mmol) and stirred under N2 atmosphere for 1 hr. The 
reaction mixture was evaporated and the residue was diluted with EtOAc and washed 
with water, dried and concentrated. The crude product was then diluted with MeCN (50 
mL) and p-ABSA (360 mg, 15 mmol) added. The solution was cooled to 0 °C, DBU was 
added drop wise and the mixture was stirred for 12 hrs. The reaction mixture was then 
evaporated, the residue dissolved in equal parts EtOAc and water and the organic phase 
was then washed with water twice, dried and concentrated. The red-brown residue was 
purified by flash column and the pale yellow product was recovered as an oil. 
 
 
 84
N
O
Ph
O O
N2
112  
 
112: 1H NMR (250 MHz, CDCl3) δ 7.37-7.12 (m, 5 H), 4.34-4.25 (m, 1 H) 4.30 
(dd, 1 H, J = 6.3, 13.2 Hz), 3.87 (d, 1 H, J = 8.8 Hz), 2.98 (dd, 1 H, J = 8.5, 13.3 Hz), 
2.81 (dd, 1 H, J = 6.3, 13.4 Hz), 2.12 (s, 1 H), 1.85 (s, 1 H), 1.53 (s, 1 H); 13C NMR (62.5 
MHz, CDCl3) δ 186.9, 156.6, 137.0, 128.8, 128.3, 126.6, 96.1, 67.8, 58.4, 40.6, 27.0, 
26.2, 22.8. 
 
N
O
O O
N2
125  
 
125: 1H NMR (250 MHz, CDCl3) δ 3.88 (dd, 1 H, J = 5.6, 8.6 Hz), 3.73 (m, 1 H), 
3.62 (dd, 1 H, J = 2.7, 8.7 Hz), 2.16 (s, 3 H), 1.49 (s, 3 H), 1.41 (m, 2 H), 1.35 (s, 3 H), 
1.08 (m, 1 H); 0.72 (t, 3 H, J = 7.3 Hz); 13C NMR (62.5 MHz, CDCl3) δ 188.9, 156.3, 
95.9, 74.3, 67.7, 57.1, 36.2, 27.1, 26.3, 23.4, 19.1, 13.6. 
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 134: 1H NMR (250 MHz, CDCl3) δ 7.31-7.06 (m, 5 H), 4.74 (t, 1 H, J = 4.5 Hz), 
3.14 (d, 2 H, J = 4.8 Hz), 2.77 (s, 3 H), 2.24 (s, 3 H), 1.56 (s, 3 H), 1.05 (s, 3 H); 13C 
NMR (62.5 MHz, CDCl3) δ 186.8, 166.8, 157.8, 135.5, 129.1, 128.2, 126.8, 80.0, 59.6, 
53.1, 37.6, 26.4, 23.9, 23.0, 22.7. 
 
General Preparation of α-Diazo-acetamides. 
 To a mixture of 5:1 water/MeCN (13.3 mL) was added the α-diazo-α-
(acetyl)acetamide (10 mmol) followed by LiOH (1.47 g, 35 mmol). The reaction mixture 
was then stirred at r.t. for 20 hrs. The solvent was evaporated and the residue dissolved in 
EtOAc. The organic solution was then washed with water twice and dried. Flash column 
chromatography was used for purification of the product. 
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 113: 1H NMR (250 MHz, CDCl3) δ 7.37-7.19 (m, 5 H), 4.83 (s, 1 H), 3.87 (s, 2 
H), 3.70 (m, 1 H), 3.02 (dd, 1 H, J = 2.0, 12.8 Hz), 2.82 (dd, 1 H, J = 10.3, 13.1 Hz), 1.73 
(s, 3 H), 1.58 (s, 3 H). 
 
N
O
O
N2
H
126  
 
 126: 1H NMR (250 MHz, CDCl3) δ 4.76 (s, 1 H), 3.80 (dd, 1 H, J = 5.3, 8.9 Hz), 
3.67 (d , 1 H, 8.8 Hz), 3.36 (m, 1 H), 1.51 (s, 3 H), 1.46 (m, 2 H), 1.40 (s, 3 H), 1.18 (m, 
2 H), 0.83 (t, 3 H, J = 7.0 Hz); 13C NMR (62.5 MHz, CDCl3) δ 161.8, 95.2, 66.8, 57.2, 
47.9, 35.8, 26.9, 23.3, 19.5, 13.7. 
 
N
O
O
EtO2C
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 114: 1H NMR (250 MHz, CDCl3) δ 4.30 (m, 1 H), 4.25 (q, 2 H, J = 7.6 Hz), 4.16 
(dd, 1 H, J = 5.8, 8.1 Hz), 4.04 (d, 1 H, J = 11.9 Hz), 3.83 (dd, 1 H, J = 8.6, 12.6 Hz), 
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3.77 (t, 1H, J = 8.6 Hz), 1.71 (s, 3 H), 1.50 (s, 3 H), 1.25 (t, 3 H, J = 7.6 Hz); 13C NMR 
(62.5 MHz, CDCl3) δ 168.5, 165.1, .137.4, 129.1, 127.8, 127.0, 92.1, 69.0, 65.1, 61.7, 
60.9, 48.7, 26.5, 23.7, 14.1. 
 
N
O
O
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 115: 1H NMR (250 MHz, CDCl3) δ 7.36-7.20 (m, 5 H), 4.27 (m, 1 H), 4.19 (m, 1 
H), 4.13 (m, 1 H), 3.90 (dd, 1 H, J = 8.6, 11.1 Hz) 3.67 (t, 1 H, J = 8.6 Hz) 2.39 (s, 3 H), 
1.65 (s, 3 H), 1.51 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 202.2, 165.3, 138.3, 129.0, 
127.6, 127.3, 91.9, 69.2, 67.4, 64.7, 45.4, 31.1, 26.6, 23.7. 
 
N
O
H
H
O
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 116: 1H NMR (250 MHz, CDCl3) δ 6.58 (m, 2 H), 6.27 (d, 2 H, J = 9.1 Hz), 6.07 
(s, 1 H), 5.12 (dd, 1 H, J = 5.4, 9.0 Hz), 4.20 (dd, 1 H, J = 5.1, 7.5 Hz), 3.70 (m, 2 H), 
2.76 (dd, 1 H, J = 2.0, 14.8 Hz), 2.47 (m, 2 H), 1.68 (s, 3 H), 1.62 (s, 3 H); 13C NMR 
(62.5 MHz, CDCl3) δ 168.1, 131.7, 130.4, 129.9, 127.2, 121.4, 119.4, 94.9, 69.1, 57.0, 
47.7, 34.7, 25.4, 24.0. 
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 128: 1H NMR (250 MHz, CDCl3) δ 4.08 (dd, 1 H, J = 5.6, 8.2 Hz), 3.74 (m, 1 H), 
3.60 (d, 1 H, J = 11.0 Hz), 3.48 (t, 1 H, J = 9.1 Hz), 2.54 (m, 1 H), 2.37 (s, 3 H), 1.54 (s, 
3 H), 1.41 (s, 3 H), 1.33 (m, 1 H), 0.81 (t, 3 H, J = 4.3 Hz); 13C NMR (62.5 MHz, CDCl3) 
δ 203.0, 166.0, 91.3, 69.5, 66.3, 64.1, 42.0, 30.8, 26.5, 25.3, 23.6, 12.1. 
 
N
O
O
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H
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 127: 1H NMR (250 MHz, CDCl3) δ 3.99 (dd, 1 H, J = 5.8, 8.3 Hz), 3.71 (m, 1 H), 
3.64 (s, 3 H), 3.46 (dd, 1 H, J = 8.8, 8.8 Hz), 3.40 (d, 1 H, J = 11.3 Hz), 2.38 (qt, 1 H, J = 
2.5, 8.5 Hz), 1.49 (s, 3 H), 1.44 (m, 2 H), 1.30 (s, 3 H), 0.73 (t, 3 H, J = 7.3 Hz); 13C 
NMR (62.5 MHz, CDCl3) δ 169.5, 165.7, 91.3, 69.1, 64.4, 60.0, 52.4, 45.3, 26.3, 25.0, 
23.5, 11.8. 
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 135: 1H NMR (250 MHz, CDCl3) δ 7.90-7.44 (m, 5 H), 7.29-7.23 (m, 5 H), 4.51 
(d, 1 H, J = 9.1 Hz), 4.14 (m, 2 H), 2.80 (s, 3 H), 1.78 (s, 3 H), 1.46 (s, 3 H). 
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 136: 1H NMR (250 MHz, CDCl3) δ 7.45-7.13 (m, 5 H), 4.30 (d, 1 H, J = 9.2 Hz), 
4.10 (dd, 1 H, J = 9.2, 10.5 Hz), 3.95 (d, 1 H, J = 11.7 Hz), 3.74 (s, 3 H), 2.82 (s, 3 H), 
1.84 (s, 3 H), 1.47 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 168.7, 167.6, 167.2, 136.7, 
128.9, 127.7, 127.5, 76.9, 63.1, 58.0, 52.8, 47.8, 24.6, 24.5, 23.2. 
 
N
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O
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 137: 1H NMR (250 MHz, CDCl3) δ 7.39-7.24 (m, 5 H), 4.30 (d, 1 H, J = 9.0 Hz), 
4.13 (d, 1 H, J = 10.7, 33.0 Hz), 4.11 (d, 1 H, J = 13.1 Hz), 2.80 (s, 3 H), 2.39 (s, 3 H), 
1.79 (s, 3 H), 1.48 (s, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 201.3, 167.5, 167.0, 137.1, 
128.4, 128.2, 127.2, 127.1, 76.4, 64.0, 62.3, 44.7, 30.7, 24.1, 22.7. 
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Preparation of Ot-Bu-(L)-Serine Methyl Ester 
 
NH2
CO2H
OH
(L)-serine
i) HCl(g), MeOH, ∆
ii) isobutylene, p-TsOH, 
    CH2Cl2
153
NH2
CO2Me
Ot-Bu
 
 
 Thionyl chloride (38 mL, 0.53 mol) was added to a solution of (L)-serine (50 g, 
0.48 mol) in MeOH (0.5 L) at 0 °C and the resulting mixture was refluxed for 2 hours. 
After concentration, the residue was solidified from ether to give (L)-serine methyl ester 
HCl salt as white solid. Liquid isobutylene (200 mL) was added to a mixture of (L)-
serine methyl ester HCl salt (20 g, 0.12 mol), p-TsOH (40 g, 0.12 mol) and CH2Cl2 (400 
mL) in a thick-walled, well-stoppered flask at –78°C and the resulting mixture was 
stirred for 72 hours at room temperature. After degassing, the reaction mixture was 
concentrated and the residue was diluted with EtOAc, washed with saturated NaHCO3, 
dried over anhydrous Na2SO4, and concentrated to afford 153, which was used for the 
next step without further purification: 1H NMR (250 MHz, CDCl3) δ 3.72 (s, 3 H), 3.59 
(br s, 3 H), 1.82 (br s, 2 H, NH2), 1.15 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 173.9, 
72.4, 63.5, 54.7, 51.3, 26.9. 
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Preparation of Amino Alcohol 154 
 
153
NH2
CO2Me
Ot-Bu
154
NH2
Ot-Bu
OHLAH
THF, 0 °C
 
 
 A solution of 153 (24 g, 0.14 mol) in anhydrous THF was added to the mixture of 
lithium aluminum hydride (31g, 0.27 mol) in THF (450 mL) at 0 °C. The resulting 
reaction mixture was stirred for 8 hrs. at room temperature and quenched by successive 
addition of water (30 mL)-20% NaOH (30 mL)-water (60 mL). The precipitate was 
filtered and washed with THF. The filtrate was dried and concentrated to give amino 
alcohol 154 as an oil, which was used for the next step without further purification: 1H 
NMR (250 MHz, CDCl3) δ 3.58 (m, 2 H), 3.39 (d, 2 H, J = 5.3 Hz), 3.00 (m, 1 H), 1.19 
(s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 72.6, 64.5, 64.3, 51.9, 26.9. 
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Preparation of N,O-Acetonide 155 
 
154
NH2
Ot-Bu
OH Me2CO/1,2-DCE
Na2SO4, ∆
HN
O
Ot-Bu
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 The mixture of the amino alcohol 154 (12 g, 80 mmol), acetone (200 mL), and 
anhydrous Na2SO4 (68 g, 0.48 mol) in 1,2-dichloroethane (200 mL) was refluxed with 
stirring for 2 hrs. The reaction mixture was filtered and concentrated to give acetonide 
intermediate 155. 
 
Preparation of N-Acylated N,O-Acetonides 156 and 157 
 
N
O
Ot-Bu
X
O
X = Br
Cl
156
157
X
X
O
TEA, CH2Cl2
HN
O
Ot-Bu
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 Bromoacetyl bromide or chloroacetyl chloride (80 mmol) was added to a mixture 
of acetonide 155 (15 g, 80 mmol) and TEA (17 mL, 160 mmol) in CH2Cl2 (160 mL) at 0 
°C. After stirring for 4 hrs. at room temperature, the reaction mixture was washed with 
water, and the aqueous layer was extracted with CH2Cl2. The combined organic layers 
were washed with brine, dried over Na2SO4 and evaporated to give the corresponding α-
haloamide 156/157, which was used for the next step without further purification. For 
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compound 156: 1H NMR (250 MHz, CDCl3) δ 4.32 (ABq, 1 H, JAB = 10.7 Hz), 4.10 (m, 
1 H), 4.00 (m, 1 H), 3.83 (d, 1 H, J = 9.7 Hz), 3.79 (ABq, 1 H, JAB = 10.7 Hz), 3.43 (d, 2 
H, J = 7.0 Hz), 1.66 (s, 3 H), 1.53 (s, 3 H), 1.18 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 
164.7, 95.6, 73.7, 65.7, 63.5, 58.0, 29.8, 27.3, 26.9, 22.0; IR (thin film, cm-1) 2976, 1648, 
1415, 1365, 1264, 1193, 726, 705. Anal. Calcd. for C12H22BrNO3: C, 46.76; H, 7.19; N, 
4.54. Found: C, 46.29; H, 7.21; N, 4.58, 161: 
 
Preparation of α-Phenylsulfonylacetamide 158 
 
N
O
Ot-Bu
X
O
X =
N
O
Ot-Bu
PhSO2
O
158Br
Cl
156
157
NaSO2Ph
DMF
 
 
 PhSO2Na (84 mmol) was added to a solution of haloacetyl amide 156/157 (80 
mmol) in DMF (160 mL) at room temperature. After stirring for 6 hrs. the reaction 
mixture was diluted with EtOAc, washed with water twice, dried over Na2SO4 and 
concentrated. The residue was purified by column chromatography to give α-
phenylsulfonyl acetamide 158: 1H NMR (250 MHz, CDCl3) δ 7.90-7.52 (m, 5 H), 5.10 
(ABq, 1 H, JAB = 14.0 Hz), 4.47 (m, 1 H), 4.04 (ABX, 1 H, JAB = 9.2 Hz, JAX = 5.3 Hz),  
3.91 (ABq, 1 H, JAB = 14.0 Hz), 3.77 (ABX, 1 H, JAB = 9.2 Hz, JAX = 0 Hz), 3.42 (d, 2 H, 
J = 7.3 Hz), 1.57 (s, 3 H), 1.49 (s, 3 H), 1.15 (s, 9 H); IR (thin film, cm-1) 2980, 1651, 
1423, 1366, 1320, 1157, 741. Anal. Calcd. for C18H27NO5S: C, 58.51; H, 7.37; N, 3.79; 
 94
S, 8.68. Found: C, 58.41; H, 7.20; N, 3.81; S, 8.72. 
 
Preparation of α-Diazo-α-(phenylsulfonyl)acetamide 163. 
 
N
O
Ot-Bu
PhSO2
O
N
O
Ot-Bu
PhSO2
O
N2
159158
p-ABSA
DBU, MeCN
 
 
 To a solution of α-phenylsulfonylacetamide 158 (6.8 g, 18 mmol) in acetonitrile 
(90 mL) was added p-ABSA (5.2 g, 21 mmol) followed by DBU (6.8 mL. 45 mmol). The 
reaction mixture was stirred for 1 hr. at 0 °C. After evaporation of acetonitrile the residue 
was diluted with EtOAc. The organic layers were washed with water twice, dried over 
Na2SO4 and then evaporated. The residue was purified by column chromatography to 
give α-diazo-α-(phenylsulfonyl)acetamide 159 as yellow solid: 1H NMR (250 MHz, 
CDCl3) δ 8.02 (d, 2 H, J = 7.1 Hz), 7.57 (m, 3 H), 3.99-3.91 (m, 3 H), 3.37 (m, 2 H), 1.59 
(s, 3 H), 1.41 (s, 3 H), 1.16 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 154.2, 142.2, 133.6, 
129.0, 127.7, 96.8, 74.7, 73.5, 66.3, 61.9, 57.1, 27.2, 26.6, 23.5; IR (thin film, cm-1) 2976, 
2092, 1628, 1395, 1267, 1150, 1085, 745.  
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Preparation of γ-Lactam 160 
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O
O
t-BuO H
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Rh2(OAc)4
CH2Cl2, ∆
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O
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O
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 To a solution of the α-diazo-α-(phenylsulfonyl)acetamide 159 (6.0 g, 15 mmol) 
in dry CH2Cl2 (300 mL, C = 0.05 M) was added catalytic amount of Rh2(OAc)4 (66 mg, 
0.15 mmol). The mixture was refluxed with stirring for 12 hrs. under N2, cooled to room 
temperature, and was then concentrated. The residue was purified by column 
chromatography to give γ-lactam 160 as a single isomer: 1H NMR (250 MHz, CDCl3) δ 
7.95 (d, 2 H, J = 7.3 Hz), 7.67-7.51 (m, 3 H), 4.69 (dd, 1 H, J = 3.75, 6.0 Hz), 4.25 (d, 1 
H, J = 6.0 Hz), 4.14 (ABX, 1 H, JAB = 8.9 Hz, JAX = 5.8 Hz), 3.96 (m, 1 H), 3.62 (ABX, 
JAB = 8.9 Hz, JBX = 8.0 Hz), 1.58 (s, 3 H), 1.39 (s, 3 H), 1.25 (s, 9 H); 13C NMR (62.5 
MHz, CDCl3) δ 161.1, 138.1, 134.1, 129.5, 128.7, 92.9, 76.9, 76.1, 67.6, 67.4, 67.3, 28.3, 
26.9, 23.4; IR (thin film, cm-1) 2977, 1705, 1401, 1321, 1266, 1153, 1080, 889, 840, 737. 
Anal. Calcd. for  C18H25NO5S: C, 58.83; H, 6.86; N, 3.81; S, 8.73. Found: C, 58.80; H, 
6.78; N, 3.98; S, 8.68. 
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Preparation of α-Methylated γ-Lactam 161 
 
N
O
O
t-BuO H
160
PhSO2
161
MeI, NaH
DMF, 0 °C
N
O
O
t-BuO H
PhSO2
 
 
 MeI (2.6 mL, 42 mmol) was added to a mixture of γ-lactam 160 (5.0 g, 14 mmol) 
and NaH (1.1 g, 28 mmol) in DMF (28 mL) at 0 °C. After stirring for 1 hour at 0 °C, the 
reaction was quenched with saturated NH4Cl, extracted with EtOAc, dried over Na2SO4 
and concentrated to give methylated γ-lactam 161: 1H NMR (250 MHz, CDCl3) δ 7.90-
7.51 (m, 5 H), 4.84 (d, 1 H, J = 4.0 Hz), 4.18 (ABX, 1 H, JAB = 8.7 Hz, JAX = 5.3 Hz), 
3.92 (m, 1 H), 3.79 (ABX, 1 H, JAB = 8.7 Hz, JBX = 7.7 Hz), 1.68 (s, 3 H), 1.51 (s, 3 H), 
1.47 (s, 3 H), 1.28 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 165.6, 135.6, 134.0, 131.3, 
128.2, 92.6, 78.9, 76.0, 67.6, 67.5, 67.4, 28.4, 26.9, 23.2, 14.6; IR (thin film, cm-1) 2979, 
1707, 1405, 1306, 1265, 1189, 1151, 1114, 742. Anal. Calcd. for  C19H27NO5S: C, 59.82; 
H, 7.13; N, 3.67; S, 8.41. Found:  C, 59.87; H, 7.00; N, 3.73; S, 8.42. 
 97
Preparation of Reduced γ-Lactam 161 
 
N
O
O
t-BuO H
PhSO2
161
N
O
O
t-BuO H
162
10% Na(Hg)
MeOH, 0 °C
 
 
 10% Sodium amalgam (12 g) was added to a solution of α-methylated γ-lactam 
161 (5.0 g, 13 mmol) and anhydrous disodium hydrogen phosphate (11 g) in dry 
methanol (250 mL) at 0 °C. The mixture was stirred for 2 hrs., quenched with water, and 
extracted twice with ether. The combined organic layers were dried over Na2SO4, filtered 
and concentrated to give 162: 1H NMR (250 MHz, CDCl3) δ 4.14 (m, 1 H), 4.03 (m, 2 
H), 3.58 (br t, 1 H), 2.67 (m, 1 H), 1.66 (s, 3 H), 1.44 (s, 3 H), 1.23 (d, 3 H, J = 7.5 Hz), 
1.17 (s, 9 H); 13C NMR (62.5 MHz, CDCl3) δ 173.2, 91.5, 74.2, 72.5, 68.2, 64.8, 48.9, 
28.0, 26.5, 23.7, 11.0; IR (thin film, cm-1) 2983, 1699, 1456, 1402, 1364, 1263, 1191, 
1101, 1039, 745. Anal. Calcd. for  C13H23NO3: C, 64.70; H, 9.61; N, 5.80. Found:  C, 
64.19; H, 9.59; N, 3.79. 
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Preparation of Carboxylic Acid 164 
 
H2CrO4
NH
O
t-BuO
CO2H
164
Me2CO
N
O
O
t-BuO H
162  
 
 Jones reagent (1.0 M, 103 mL, 103 mmol) was added to a solution of 162 (4.2 g, 
17 mmol) in acetone (340 mL) at 0 °C and the resulting mixture was stirred for 2 hrs. at 
that temperature. The reaction was quenched with IPA, extracted three times with 
CH2Cl2, dried over Na2SO4 and concentrated to give carboxylic acid 164, which was 
used for the next step without further purification. 
 
Preparation of Methyl Ester 165 
 
NH
O
t-BuO
CO2H
NH
O
t-BuO
CO2Me
TMOF
MeOH, H2SO4
165164  
 
 A mixture of the carboxylic acid 164 and trimethyl orthoformate (19 mL, 170 
mmol) in methanol (340 mL) containing a catalytic amount of sulfuric acid (2-3 drops) 
was stirred for 4 hours at room temperature. The reaction mixture was neutralized by 
addition of solid NaHCO3 and evaporated. The residue was diluted with water, extracted 
with CH2Cl2, dried over Na2SO4, concentrated and purified by column chromatography 
 99
to afford 165: 1H NMR (250 MHz, CDCl3) δ 5.91 (br s, 1 H), 4.36 (br d, 1 H, J = 7.0 Hz), 
4.04 (br s, 1 H), 3.77 (s, 3 H), 2.50 (dq, 1 H, J = 7.0 Hz, 7.3 Hz), 1.23 (s, 9 H), 1.13 (d, 3 
H, J = 7.3 Hz); 13C NMR (62.5 MHz, CDCl3) δ 179.4, 171.3, 74.9, 73.0, 63.2, 52.4, 39.8, 
27.9, 8.8. Anal. Calcd. for  C11H19NO4: C, 57.62; H, 8.35; N, 6.11. Found:  C, 56.71; H, 
8.31; N, 5.93. 
 
Preparation of Iminoether 166 
 
N
O
t-BuO
CO2Me
166
Me3O·BF4
CH2Cl2
NH
O
t-BuO
CO2Me
165  
 
 To a mixture of 165 (2.6 g, 11 mmol) and 4 Å molecular sieve in dry CH2Cl2 (110 
mL) was added a solution of trimethyloxonium tetrafluoroborate (4.8 g, 31 mmol) in 
CH2Cl2 (60 mL) at 0 °C. The reaction mixture was stirred for 3 hrs., filtered and poured 
into an aqueous solution of K2CO3. The aqueous layer was extracted with CH2Cl2 and the 
combined organic layers were dried over Na2SO4, concentrated and chromatographed to 
give 166: 1H NMR (250 MHz, CDCl3) δ 4.38 (dd, 1 H, J = 4.3, 7.3 Hz), 4.29 (d, 1 H, J = 
4.3 Hz), 3.89 (s, 3 H), 3.74 (s, 3 H), 2.79 (dq, 1 H, J = 7.3 Hz, 7.3 Hz), 1.25 (s, 9 H), 1.08 
(d, 3 H, J = 7.3 Hz); 13C NMR (62.5 MHz, CDCl3) δ 176.7, 173.0, 75.2, 74.4, 74.0, 55.3, 
52.0, 42.0, 28.0, 10.0; Anal. Calcd. for C12H21NO4: C, 59.24; H, 8.70; N, 5.76. Found: C, 
58.65; H, 8.75; N, 5.77. 
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Preparation of α-Methylene γ-Lactam. 
 
N
O
O
t-BuO H
10% Na(Hg)
MeOH, 0 °C
163
N
O
O
t-BuO H
160
PhSO2
 
 
10% Sodium amalgam (7.8 g) was added to a solution of γ-lactam 160 (3.0 g, 8.4 
mmol) and anhydrous disodium hydrogen phosphate (7.0 g) in dry methanol (160 mL) at 
0 °C. The mixture was stirred for 2 hrs., concentrated, diluted with water and extracted 
with ether twice. The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was chromatographed to give reduced γ-lactam 163: 1H NMR 
(250 MHz, CDCl3) δ 4.09 (m, 3 H), 3.54 (dd, 1 H, J = 7.1, 7.9 Hz), 2.73 (m, 2 H), 1.62 (s, 
3 H), 1.42 (s, 3 H), 1.14 (s, 9 H). 
 
Preparation of α-Methylated γ-Lactam epi-162 
 
N
O
O
t-BuO H
N
O
O
t-BuO H
epi-162163
MeI
LHMDS, -78 °C
 
 
 To a solution of reduced γ-lactam 163 (250 mg, 1.0 mmol) in THF (5.0 mL) was 
added a solution of LHMDS in THF (1.2 mmol) at -78°C. After stirring for 15 min at that 
temperature, MeI (11 µL, 1.2 mmol) was added to the reaction mixture, which was 
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further stirred for 30 min. and quenched with saturated NH4Cl. The aqueous layer was 
extracted with EtOAc and the combined organic layers were washed with brine, dried 
over Na2SO4 and concentrated. The residue was chromatographed to give epi-162: 1H 
NMR (250 MHz, CDCl3) δ 4.15 (dd, 1 H, J = 5.7, 8.2 Hz), 3.96 (m, 1 H), 3.55 (m, 2 H), 
2.78 (dq, 1 H, J = 7.1, 9.7 Hz), 1.62 (s, 3 H), 1.46 (s, 3 H), 1.19 (d, 3 H, J = 7.1 Hz), 1.17 
(s, 9 H). 
 
Preparation of Carboxylic Acid epi-164 
 
H2CrO4
NH
O
t-BuO
CO2H
epi-164
Me2CO
N
O
O
t-BuO H
epi-162  
 
 Following the same procedures for the preparation of 164, epi-164 was obtained 
from epi-162 in a 56% yield: 1H NMR (250 MHz, CDCl3) δ 6.2 (br s, 1 H), 4.1 (d, 1 H, J 
= 3.0 Hz), 4.0 (br s, 1 H), 3.77 (s, 3 H), 2.34 (dq, 1 H, J = 3.0, 7.6 Hz), 1.21 (d, 3 H, J = 
7.6 Hz), 1.21 (s, 9 H). 
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Preparation of Methyl Ester epi-165 
 
NH
O
t-BuO
CO2Me
epi-165
MeOH, H2SO4
NH
O
t-BuO
CO2H
epi-164
TMOF
 
 
 Following the same procedures for the preparation of 165, epi-165 was obtained 
from epi-164 in a 70% yield: 1H NMR (250 MHz, CDCl3) δ 6.23 (s, 1 H), 4.04 (m, 2 H), 
3.77 (s, 3 H), 2.34 (qd, 1 H, J = 3.0, 7.8 Hz), 1.21 (m, 12 H). 
 
Preparation of Iminoether epi-166 
 
N
O
t-BuO
CO2Me
epi-166
Me3O·BF4
CH2Cl2
NH
O
t-BuO
CO2Me
epi-165  
 
 Following the same procedures for the preparation of 166, epi-166 was obtained 
from epi-165 in a 70% yield: 1H NMR (250 MHz, CDCl3) δ 4.29 (d, 1 H, J = 3.2 Hz), 
4.09 (dd, 1 H, J = 3.3, 3.6 Hz), 3.83 (s, 3 H), 3.75 (s, 3 H), 2.65 (m, 1 H), 1.22 (d, 3 H, J 
= 7.6 Hz), 1.18 (s, 9 H). 
 103
Preparation of Aldol Coupling Product epi-167 
 
N
O
t-BuO
CO2Me
epi-166
N
t-BuO
O
CO2Me
HO
epi-167
isobutyraldehyde
LDA, -78 °C
 
 
 To a solution of iminoether epi-166 (250 mg, 1.0 mmol) in THF (5.0 mL) was 
added a solution of LDA in THF (1.2 mmol) at -78 °C. After stirring for 15 min. at that 
temperature, isobutyraldehyde (11 µL, 1.2 mmol) was added to the reaction mixture, 
which was further stirred for 30 min. and quenched with saturated NH4Cl. The aqueous 
layer was extracted with EtOAc and the combined organic layers were washed with 
brine, dried over Na2SO4 and concentrated. The residue was chromatographed to give 
aldol product epi-167 as a single isomer: 1H NMR (250 MHz, CDCl3) δ 4.22 (d, 1 H, J = 
4.1 Hz), 3.94 (dd, 1 H, J = 3.4, 11.1 Hz), 3.85 (s, 3 H), 3.69 (s, 3 H), 2.64 (m, 1 H), 1.95 
(m, 1 H), 1.23 (d, 3 H, 7.4 Hz), 1.15 (s, 9 H), 1.00 (d, 6 H, J = 6.8 Hz). 
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Preparation of Aldol Coupling Products 167 5R, 9S / 167 5S 
 
N
O
t-BuO
CO2Me
166
N
t-BuO
O
CO2Me
HO
167 5R, 9S / 167 5S
isobutyraldehyde
LDA, -78 °C
2:1 ratio of diastereomers 
 
 Following the same procedure for epi-167, aldol reaction of 166 afforded an 
inseparable mixture 167 5R, 9S and 167 5S in 70% yield. 167 5R, 9S: 1H NMR (250 
MHz, CDCl3) δ 4.64 (d, 1 H, J = 8.67 Hz), 3.95 (dd, 1 H, J = 3.0, 10.9 Hz), 3.85 (s, 3 H), 
3.67 (s, 3 H), 2.68 (m, 1 H), 1.92 (m, 1 H), 1.15 (s, 9 H), 1.07 (d, 3 H, J = 7.6 Hz), 1.01 
(d, 3 H, J = 6.76 Hz), 0.99 (d, 3 H, J = 6.7 Hz). 167 5S: 1H NMR (250 MHz, CDCl3) δ 
4.36 (d, 1 H, J = 9.5 Hz), 4.08 (dd, 1 H, J = 3.4, 5.5 Hz), 3.87 (s, 3 H), 3.70 (s, 3 H), 3.23 
(d, 1 H, J = 3.4 Hz), 2.73 (m, 1 H), 1.85 (m, 1 H), 1.22 (s, 9 H), 1.11 (d, 3 H, J = 7.5 Hz), 
1.04 (d, 3 H, J = 6.7 Hz), 0.94 (d, 3 H, J = 6.9 Hz). 
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Preparation of β-Keto Esters 172R and 172S. 
 
Dess-Martin N
t-BuO
O
CO2Me
O
168R & S
N
t-BuO
O
CO2Me
HO
167 5R, 9S / 167 5S
2:1 ratio of diastereomers  
 
 The mixture of β-keto esters 167 5R, 9S and 167 5S were dissolved in CH2Cl2 
and cooled to 0 °C. Excess DMP solution was added and the reaction was quenched after 
5 min. using saturated sodium bicarbonate solution. The organic solution was washed 
with water, dried and concentrated. The products were separated using flash column 
chromatography. 168 5R: 1H NMR (250 MHz, CDCl3) δ 5.10 (d, 1 H, J = 8.5 Hz), 3.86 
(s, 3 H), 3.74 (s, 3 H), 3.06 (m, 1 H), 2.71 (m, 1 H), 1.15 (s, 9 H + 3 H), 1.11 (d, 3 H, J = 
7.6 Hz), 1.08 (d, 3 H, J = 6.8 Hz). 168 5S: 1H NMR (250 MHz, CDCl3) δ 5.11 (d, 1 H, J 
= 8.0 Hz), 3.90 (s, 3 H), 3.75 (s, 3 H), 2.87 (m, 2 H), 1.15 (s, 9 H + 3 H), 1.09 (d, 3 H, J = 
7.8 Hz), 1.04 (d, 3 H, J = 6.8 Hz). 
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Preparation of Dihydroxy Esters 169 5R, 9S and 169 5S. 
 
NH
HO
O
CO2Me
HO
167 5R, 9S/167 5S
2:1 ratio of diastereomers
TFA
1% HCl
NH
HO
O
CO2H
HO
169 5R, 9S/169 5S 170 5R, 9S/170 5S
LiOH
MeOH
 
 
 A solution of aldol products 167 5R, 9S and 167 5S (160 mg, 0.51 mmol) in 
trifluoroacetic acid (2.5 mL) was stirred for 1 hr. at room temperature. After 
concentration, the crude diol compounds were dissolved in a solution of 1% HCl in 
EtOH. The mixture was stirred for 1 hour, concentrated, diluted with EtOAc, washed 
with saturated NaHCO3 and dried over Na2SO4. After concentration, the residue was 
chromatographed to afford an inseparable mixture of dihydroxy γ-lactams 169 5R, 9S and 
169 5S. 169 5R, 9S: 1H NMR (250 MHz, CD3OD) δ 4.43 (d, 1 H, J = 6.0 Hz), 3.90 (d, 1 
H, J = 7.3 Hz), 3.72 (s, 3 H), 2.94 (m, 1 H), 1.65 (m, 1 H), 1.06 (d, 3 H, J = 7.6 Hz), 0.97 
(d, 3 H, J = 6.6 Hz), 0.83 (d, 3 H, J = 6.8 Hz). 169 5S: 1H NMR (250 MHz, CD3OD) δ 
4.61 (d, 1 H, J = 5.8 Hz), 3.95 (d, 1 H, J = 5.1 Hz), 3.74 (s, 3 H), 2.48 (m, 1 H), 1.76 (m, 
1 H), 1.10, (d, 3 H, J = 7.3 Hz), 1.01 (d, 3 H, J = 6.8 Hz), 0.93 (d, 3 H, J = 6.68 Hz). 
 
Preparation of clasto-Lactacystin β-Lactone 2 
 A mixture of dihydroxy γ-lactams 169 5S & 169 5R, 9S in 0.1 N NaOH/EtOH 
solution was stirred for 4 hrs. at r.t. The reaction mixture was neutralized with saturated 
NH4Cl and concentrated to give a mixture of dihydroxy acids. To the mixture of 
dihydroxy acids and TEA in THF was added isopropenyl chloroformate at 0 °C and 
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stirred for 1 hour. The reaction mixture was diluted with water, extracted with CH2Cl2, 
dried over anhydrous. Na2SO4, concentrated and purified by column chromatography to 
afford 2. 1H NMR (250 MHz, Pyridine d5) δ 10.47 (s, 1 H), 7.87 (d, 1 H, J = 6.8 Hz), 
5.69 (d, 1 H, J = 6.1 Hz), 4.36 (dd, 1 H, J = 3.7, 6.8 Hz), 3.06 (m, 1 H), 2.12 (m, 1 H), 
1.48 (d, 3 H, J = 7.5 Hz), 1.13 (d, 3 H, J = 6.9 Hz), 1.02 (d, 3 H, J = 6.7 Hz). 
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Appendix A: Selected 1H NMR and 13C NMR Spectra 
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Appendix B: X-Ray Crystallographic Data 
 
  Table 1.  Crystal data and structure refinement for (2) bdm1. 
Identification code  bdm1 
Empirical formula  C10 H15 N O4 
Formula weight  213.23 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.2118(6) Å α = 90°. 
 b = 8.2964(7) Å β = 90°. 
 c = 18.2095(16) Å γ = 90°. 
Volume 1089.51(16) Å3 
Z 4 
Density (calculated) 1.300 Mg/m3 
Absorption coefficient 0.101 mm-1 
F(000) 456 
Crystal size 0.20 x 0.20 x 0.03 mm3 
Theta range for data collection 2.24 to 28.31°. 
Index ranges -9<=h<=9, -10<=k<=11, -21<=l<=24 
Reflections collected 9626 
Independent reflections 2608 [R(int) = 0.0586] 
Completeness to theta = 28.31° 98.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2608 / 0 / 139 
Goodness-of-fit on F2 0.944 
Final R indices [I>2sigma(I)] R1 = 0.0404, wR2 = 0.0782 
R indices (all data) R1 = 0.0495, wR2 = 0.0806 
Absolute structure parameter 0.8(11) 
Largest diff. peak and hole 0.286 and -0.169 e.Å-3 
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Appendix B: (Continued) 
 
  Table 7.  Crystal data and structure refinement for (epi-167) df01m. 
Identification code  df01m 
Empirical formula  C16 H29 N O5 
Formula weight  315.40 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  ? 
Space group  ? 
Unit cell dimensions a = 6.15(2) Å α= 90°. 
 b = 15.20(5) Å β= 104.57(4)°. 
 c = 9.89(3) Å γ= 90°. 
Volume 895(5) Å3 
Z 2 
Density (calculated) 1.171 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 344 
Crystal size 0.30 x 0.20 x 0.10 mm3 
Theta range for data collection 2.13 to 28.37°. 
Index ranges -7<=h<=8, -20<=k<=20, -13<=l<=13 
Reflections collected 13194 
Independent reflections 4231 [R(int) = 0.0481] 
Completeness to theta = 28.37° 97.0 %  
Max. and min. transmission 0.9915 and 0.9747 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4231 / 1 / 229 
Goodness-of-fit on F2 0.951 
Final R indices [I>2sigma(I)] R1 = 0.0436, wR2 = 0.0887 
R indices (all data) R1 = 0.0514, wR2 = 0.0917 
Absolute structure parameter -0.6(8) 
Largest diff. peak and hole 0.271 and -0.170 e.Å-3 
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epi-167 
 
